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A.1.  Program Goals and Objectives 
 
The objectives of the Medical Physics Residency Program at Vanderbilt University is 
to prepare its residents (1) to assume appropriate responsibilities in the clinical 
practice of Medical Physics in radiation oncology physics and (2) for further 
education, teaching, and research in Medical Physics.  In the present program, a 
resident is primarily prepared to enter the clinical practice of radiotherapy Medical 
Physics as a junior-level physicist working under the direct supervision of a certified 
Medical Physicist. The resident after achieving sufficient additional training and 
clinical experience (1-2 years) would be qualified to sit for the Therapeutic 
Radiological Physics Examination (written and oral) of the American Board of 
Radiology. 
 
 
                                                                                                                                                                                                  
A.2.   Program Structure and Governance 
 
     The Medical Physics Residency Program is a two-year certificate program housed 
within the Department of Radiation Oncology at the Vanderbilt School of Medicine. 
The  Chairman of Radiation Oncology is Dennis Hallahan, MD.   The Program is 
administered by the Medical Physics Residency Program Director, Charles W. 
Coffey, II, PhD. Residents of the Program receive didactic education as non-
academically registered participants in the MS Medical Physics Program of the 
Vanderbilt School of Medicine.  Residents receive radiotherapy physics clinical 
training and experience in the Clinical Physics Section of the Department of 
Radiation Oncology of the Vanderbilt School of Medicine.  Residents may also 
limitedly participate in clinical physics duties at two Vanderbilt Radiation Oncology 
Satellite Facilities, Vanderbilt-Ingram Cancer Center, Franklin, Tennessee, and 
Gateway Medical Center, Clarksville, Tennessee.  
     The Program Director is responsible for coordinating the didactic education and 
clinical training, recruiting and advising the residents, and evaluating and promoting 
the Program.  The present Program Director is the Chief Clinical Physicist in the 
Department of Radiation Oncology; he also is the supervisory medical physicist for 
the Vanderbilt Radiation Oncology satellite radiotherapy clinics in Franklin and 
Clarksville, Tennessee.  The Program Director holds a full-time academic 
appointment in the Vanderbilt University School of Medicine and a joint-appointment 
in the Department of Physics and Astronomy.  The Program Director is assisted in his 
various duties by the Medical Physics Residency Program Advisory Committee.    4
Advisory committee members include two PhD physics faculty members, one 
radiation oncologist faculty member, two MS physics staff members, and one 
dosimetry staff member from the Department of Radiation Oncology.  Resumes of 
the Advisory Committee members are contained elsewhere in the Appendix.   
Additionally, resumes of other academic faculty members participating in the didactic 
education of the residents and clinical faculty and staff participating in the clinical 
training and experience of the residents are contained elsewhere in the Appendix. 
    Recruitment of residents is through the Department of Radiation Oncology Educational 
Office with applicant follow-up coordinated by the Program Director and Educational 
Office Coordinator.  Following official contact by an applicant, the Program Director is 
notified and a follow-up letter containing a program brochure, resident application, and 
descriptive medical physics brochures (available from AAPM HQ) are sent by the 
Program Director. Resident applications are processed through the Education Office in 
the Department of Radiation Oncology and copies of the application, transcripts, GRE 
and TOFEL scores, personal statement letter, and letters of reference) are sent to the 
Program Director.  Individual resident applications are reviewed for acceptance, non-
acceptance, or postponement by the Medical Physics Residency Program Advisory 
Committee.    
     The  Advisory  Committee  keeps  abreast  of  resident  performance  and  progression 
toward successful completion of the program. The Program Director verifies that all 
requirements are met for completion of the program.  A grievance procedure process is in 
place should the resident have an issue(s) with an academic class or clinical training 
experience.  Briefly, the resident would seek solutions to the issue(s) with the instructor, 
the Program Director, the Advisory Committee, and finally with the Dean of  Biomedical 
Education and Research of the School of  Medicine. 
 
 
 
A.3.  Program Evolution and History 
 
     Medical Physics at Vanderbilt draws upon a strong heritage in radiation physics and 
graduate education in medicine and physics.  From the 1950s to the early 1970s, 337 
students were trained in medical physics and health physics through the Atomic Energy 
Commission training program that was jointly managed at Vanderbilt by the Departments 
of Physics and Astronomy and the Nuclear Medicine Division of the Department of 
Radiology and Radiological Sciences.  Of these students, 190 received the MS Degree 
and 54 received the Ph.D. Degree.  Throughout these years, faculty in the Department of 
Physics and Astronomy with joint appointments in the Department of Radiology taught 
undergraduate and graduate courses in medical physics and radiological physics and 
conducted research in nuclear medicine and medical imaging.  Although the AEC 
training program was discontinued, faculty in Radiology continued to teach radiological 
physics courses in the Department of Physics and Astronomy. 
     In  1996,  faculty representatives  from the Departments of Physics and Astronomy, 
Biomedical Engineering, and Radiology and Radiological Sciences formed an ad hoc 
committee to investigate the creation of an Applied Physics graduate program at 
Vanderbilt.  This collaboration and cooperation resulted in the formation of an additional  5
ad hoc Medical Physics Program Committee.  The Medical Physics Program Committee 
consisted of faculty members representing the Departments of Physics and Astronomy, 
Biomedical Engineering, Radiology and Radiological Sciences and the Division of 
Radiation Oncology (the Division of Radiation Oncology became the Department of 
Radiation Oncology in 1999).    This committee prepared a MS Medical Physics Program 
Curriculum, solicited teaching and advisory faculty participants, prepared supporting 
graduate program materials documentation and submitted a proposal for a MS Medical 
Physics Program to the Department of Physics and Astronomy.  Following Physics and 
Astronomy Department approval, the proposal was submitted to the Graduate School for 
approval.  Following Graduate School approval, the proposal was submitted to the 
University Board of Trust for approval; Board of Trust approval was granted in Spring, 
1998.   
          In anticipation of Board of Trust approval, three students were admitted to the 
University as the inaugural class of the MS Medical Physics Program in Fall, 1997.  Two 
of the three original students graduated in May, 1999 (the third student dropped out of the 
program in January, 1999).  A second class of two students was recruited for Fall, 1999; 
both students obtained degrees in the Summer of 2001.  A single student made up the 
third class that entered the MS Program in Fall, 2001.  A second student joined the third 
class in January, 2002.  The fourth class of four students entered the program in Fall, 
2002.  Additionally, during the five-year existence of the program, a limited number of 
graduate students from the Department of Physics and Astronomy have taken courses in 
the Medical Physics Program curriculum.  One of these students, having completed the 
Department of Physics and Astronomy preliminary examinations, chose to pursue a PhD 
thesis research project in radiation oncology physics.  That student will complete his PhD 
degree in May 2003. In Summer 2002, the MS Medical Physics Program was moved 
administratively to the Vanderbilt University School of Medicine and was housed in the 
Departments of Radiation Oncology and Radiology and Radiological Sciences.  
      Prior to the official recognition of the MS medical physics program, two medical 
physics fellows, Dennis Duggan, PhD, (1993-1994), and Darryl Kaurin, PhD, (1997-
1999), joined the Clinical Physics Section of the Department of Radiation Oncology. 
These medical physics fellows underwent didactic instruction and clinical training similar 
to that proposed for medical physics residents.  In 1998, with an academic medical 
physics program already in place at Vanderbilt, the concept of a official medical physics 
residency education and training program for MS and PhD students became a reality.   In 
May, 1998, another medical physics fellow, Chris Scarfone, PhD, 1998-2000 was asked 
to join the Clinical Physics Section.  (Note: Vanderbilt School of Medicine administrative 
officials have declared that only medical physicians can be given the appointment of 
resident; hence our medical physicists trainees are given the appointment of medical 
physics fellow.)  The Vanderbilt Medical Physics Fellow Program was recognized 
nationally by the AAPM Development Committee with the selection of Dr. Scarfone as 
the   recipient of the ASTRO Clinical Residency Training in Radiation Oncology award 
for July 1, 1998 through June 30, 2000.  In July, 2001, Patana Puwanich, PhD, a medical 
physicist from Thailand, was appointed as a medical physics fellow in the Clinical 
Physics Section.  Dr. Puwanich will complete his didactic and clinical training on June 
30, 2003; he will return to Thailand and become the deputy director of the medical 
physics academic program at the Khon Kaen University in Khon Kaen, Thailand.  With a  6
track record of both didactic and clinical training of four clinical radiotherapy physics 
residents (fellows) at Vanderbilt, the Medical Physics Residency Advisory Committee 
and the Department of Radiation Oncology have decided to submit the self-study 
materials for accreditation by CAMPEP. 
 
 
 
 
B.1   Requirements for Program Completion 
 
     Applicants must have a PhD Degree in Medical Physics, Health Physics, Physics,  
Biomedical Engineering, or Nuclear Engineering or a MS Degree in Medical Physics.  
The residency program is twenty-four months in length.  The additional didactic medical 
physics training will be commensurate with the applicant’s prior education according to 
official college transcript(s). The maximum equivalent course credit hours per semester 
will not exceed six credits.  Excluding the time spent in class attendance per academic 
semester, the resident candidate will receive clinical training and experience in the 
Clinical Physics Section of the Department of Radiation Oncology.  The normal 
scheduled workday in the Clinical Physics Section is from 8:00 AM to 5:00 PM; 
excluding class time, the resident candidate is required to be in the Physics Section.  The 
resident candidate progress will be assessed as he/she performs clinical duties within an 
assigned clinical sub-specialty.  (In the Physics Section at Vanderbilt, a progressive job 
performance evaluation is in place; all clinical assignments are “signed off” by a second 
responsible (senior) member of the section before the assignment is assumed completed.  
Hence, immediate feedback is available for clinical assignments.)  Additionally, the 
Physics Sub-specialty Director may require an oral or written examination for clinical 
performance assessment.  At the discretion of the Program Director, the resident 
candidate may be assigned a clinical medical physics research project; the project scope 
would not exceed three-months duration. 
       During the didactic classroom experience, the resident will be asked to participate in 
the student examination process; hence the examinations will be evaluated (graded) by 
the course instructor.  The resident evaluation process will include the “second signature” 
policy that is in place in the Clinical Physics Section.  The resident will prepare reports of 
linac commissioning. beam data commissioning in a treatment planning computer, and 
quality assurance data analysis; these reports will be evaluated by the responsible senior 
physicist for that sub-specialty rotation.  The resident will be responsible to 
obtain“minimum pass” on each clinic sub-specialty rotation. 
          The graduate will be given a certificate upon completion of the program.  The 
certificate will include the program specialty field completed and the time period spent in 
the program.  The certificate will be co-signed by the Program Director and the Chairman 
of the Department of Radiation Oncology. 
 
 
B.2.   Training Essentials – Design and Content 
 
               See Appendix  7
 
 
 
 
 
 
 
B.3   Program Length and Sample Training Plans 
 
     The residency program length is twenty-four months for those applicants who have a 
PhD Degree in Medical Physics, Health Physics, Physics, Biomedical Engineering, or 
Nuclear Engineering.  The residency program length is twenty-four months for those 
applicants who have a MS Degree in Medical Physics. 
     For those applicants who do not have a graduate degree in Medical Physics, a sample 
training plan is listed below: 
 
Fall, Year 01 
Didactic Coursework: 
   Health Physics  RAD 5343   (3hrs) 
   Radiation Biophysics  RADO  5248  (2hrs) 
   Anatomy and Physiology  NUR 210A  (4hrs) 
Clinic Rotations: 
   Rotation 1  Patient Simulation, Setup, and Treatment (2wks) 
   Rotation 2  External Beam, non-3D (4wks) 
   Rotation 3A  External Beam, 3D (6wks) 
   Rotation 6  Brachytherapy, LDR (6wks) 
 
Spring, Year 01 
Didactic Coursework: 
   Radiation Interactions and Dosimetry  RADO 5304   (3hrs) 
   Anatomy and Physiology NUR 210B  (4hrs) 
Clinic Rotations: 
   Rotation 4A  External Beam, IMRT  (6wks) 
   Rotation 8A  Brachytherapy, Prostate Seed Implants (6wks) 
   Rotation 9 Brachytherapy, IVB  (6wks) 
   Reseach  (2wks) 
 
Summer, Year 01 
Clinic Rotations: 
   Rotation 12  Quality Assurance (6wks) 
   Rotation 3B External Beam, 3D (6wks) 
 
Fall, Year 02 
Didactic Coursework: 
   Clinical Therapy Physics I  RADO 5311  (3hrs) 
   Clinical Diagnostic Physics  RAD  5313  (3hrs)  8
Clinic Rotations: 
   Rotation 5 External Beam, Radiosurgery (6wks) 
   Rotation 10 Linac Commissioning (10 wks) 
 
 
 
 
Spring, Year 02 
Didactic Coursework: 
   Clinical Therapy Physics II  RADO  5312  (2hrs) 
   Laboratory in Clinical Therapy Physics RADO 5314  (2hrs) 
Clinic Rotations: 
   Rotation 7A  Brachytherapy, HDR (6wks) 
   Rotation 8B  Brachytherapy, Prostate Seed Implants (6wks) 
   Rotation 11  Treatment Planning Computer Commissioning (6 wks) 
   Research (3 wks) 
 
Summer, Year 02 
Clinic Rotations: 
   Rotation 4B  External Beam, IMRT (6 wks) 
   Rotation7B  Brachytherapy, HDR (6wks) 
   Research (3wks) 
 
 
     For those applicants who have a graduate degree in Medical Physics, a sample training 
plan is listed below: 
 
Fall, Year 01 
Didactic Coursework: 
   Clinical Therapy Physics I  RADO 5311  (3hrs) 
   Clinical Diagnostic Physics  RAD  5313  (3hrs) 
Clinic Rotations: 
   Rotation 1  Patient Simulation, Setup, and Treatment (2wks) 
   Rotation 2  External Beam, non-3D (4wks) 
   Rotation 3A  External Beam, 3D (6wks) 
   Rotation 6  Brachytherapy, LDR (6wks) 
 
Spring, Year 01 
Didactic Coursework: 
   Clinical Therapy Physics II  RADO  5312  (2hrs) 
   Laboratory in Clinical Therapy Physics RADO 5314  (2hrs) 
Clinic Rotations: 
   Rotation 4A   External Beam, IMRT (6wks) 
   Rotation  8A  Brachytherapy, Prostate Seed Implants (6wks) 
   Rotation 9  Brachytherapy, IVB (6wks) 
   Research  (2wks)  9
 
Summer, Year 01 
Clinic Rotations: 
   Rotation 12  Quality Assurance (6wks) 
   Rotation 3B  External Beam, 3D (6wks) 
 
 
Fall, Year 02 
Didactic Coursework: 
Radiation Biophysics RADO 5248 (2hrs) 
Clinic Rotations: 
  Rotation 5 External Beam, Radiosurgery (6wks) 
  Rotation 10 Linac Commissioning (10 wks) 
 
Spring Year 02 
Clinic Rotations: 
   Rotation 7A  Brachytherapy, HDR (6wks) 
   Rotation 8B  Brachytherapy, Prostate Seed Implants (6wks) 
   Rotation 11  Treatment Planning Computer Commissioning (6 wks) 
   Research (3 wks) 
 
Summer Year 02 
Clinic Rotations: 
   Rotation 4B  External Beam, IMRT (6 wks) 
   Rotation 7B  Brachytherapy, HDR (6wks) 
   Research (3wks) 
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B.4   Training Administration 
 
     Training objectives (didactic and clinical experience) will be modified to reflect the 
specific education and training background of the resident candidate.  Thus, the hours 
spent in the classroom will be modified for individual needs; it is estimated that the 
classroom equivalent semester credit hours would vary from a minimum of 10 credit 
hours to a maximum of 26 credit hours.  Additionally, individual clinic rotations may 
vary in length with respect to available patient volumes during the assigned rotation 
interval and the skills and experience acquired by the individual resident.   
 
     Didactic classroom evaluation will follow the regular examination(s) and final exam 
schedule established by the course instructor.  The resident should obtain a minimum 
grade of ‘B’ in each didactic course completed.  The resident and specific sub-specialty 
rotation supervisor will meet periodically throughout the rotation interval to discuss 
progress and remaining deficiencies.  The rotation supervisor will assess performance 
according to the Vanderbilt Physics Section double check system.  Also the rotation 
supervisor may elect to give an exit rotation written or oral examination.  The resident 
must obtain the supervisor’s signature indicating successful completion of each specific 
rotation.   
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C.1     Admissions  
  
 
     Inquiries  from  prospective  resident candidates are from contacts resulting from 
browsing the Vanderbilt School of Medicine and the Department of Radiation Oncology, 
websites, personal letters including email, and/or phone calls to the Program Director.  
Once the original contact has been made, the candidate will receive a letter from the 
Program Director highlighting the Medical Physics Residency Program and Vanderbilt 
University.    The letter further explains that candidates interested in the Medical Physics 
Residency Program can directly contact the Program Director for additional information.  
A prospective resident candidate list is generated; from this list a second letter is sent by 
the Program Director that includes the Vanderbilt Medical Physics Residency Brochure, 
describing admission requirements, program content, didactic course offerings, clinic 
rotations and faculty, The Medical Physicist, and The Roles, Responsibilities, and Status 
of the Clinical Medical Physicist.  The resident candidate is encouraged to call or 
otherwise contact the Program Director for further information.  Additionally, the 
resident is encouraged to complete and return an Admissions Packet to the Radiation 
Oncology Education Coordinator. 
     Admission requirements to the Vanderbilt Medial Physics Residency Program include 
a PhD degree in medical physics, health physics, physics, biomedical or nuclear 
engineering or a MS degree in medical physics. The candidate must however demonstrate 
a strong undergraduate physics background; as an example of a strong undergraduate 
physics background the minimum of a physics minor is suggested.  The incoming 
resident candidate should have a graduate GPA of 3.5/4.0 and a combined General GRE 
score of 1920.  In recent months, the General GRE has altered its scoring process.   
Hence, the incoming student should have a combined score of 1280 on the verbal and 
quantitative and a score of 5.0 on the written exam.  Non-USA trained candidates must, 
in addition to the above requirements, submit TOEFL and TSE scores of 650 and 375, 
respectively.   
     The  Radiation  Oncology  Education Coordinator will review the admissions 
application for completeness and receipt of all supporting materials including letters of 
recommendation, transcripts, GRE scores, and etc.  Copies of the completed application 
will be sent to the Program Director.  The Program Director will contact the resident 
candidate acknowledging that the completed application has been received and offer the 
prospective candidate his assistance should further questions or issues arise.  The 
candidate will be informed that the acceptance decision are made and sent to the student 
by March 15 (September 15).  During the months of January through March (July 
through September), the Program Director will send copies of the resident candidate  12
packets to the members of the Medical Physics Residency Program Advisory Committee.  
Meetings of the Medical Physics Residency Program Advisory Committee are called by 
the Program Director as needed to discuss student applications.  Action by the Committee 
may be to accept, reject, or postpone decision concerning the resident’s application.  This 
process is repeated until all the applications are reviewed; those postponed status 
applications will have final decisions by March 1 (September 1).  The Chairman of the 
Radiation Oncology must grant final approval of resident applications.  Candidate 
acceptance or rejection notices will be sent by March 15 (September 15) with a deadline 
for candidate response of April 15 (October 15).  Consideration of late applications will 
be at the discretion of the Medical Physics Residency Program Advisory Committee; 
availability of residency slots and considerations of financial aid will determine the 
number of late application reviews. 
 
Admissions timeline is described below: 
 
Receipt of Completed Applications                                  Jan 31 (July 31) 
Review of Applications                                                        Feb 28 (Aug 31) 
Final Approval of Accepted Applicants                               March 15 (Sept 15) 
Letter of Acceptance or Rejection Sent to Candidate           March 15 (Sept 15) 
Candidate Notification of Intent                                           April 15 (October 15)  
 
 
 
C.2   Recruitment Efforts 
 
.  During the 1999 Annual Meeting the Vanderbilt Department of Radiation Oncology 
purchased an exhibit space to promote the MS Medical Physics Program and the Medical 
Physics Residency Program.  The booth was staffed with an information person and 
literature about the programs.  Also Vanderbilt was a cosponsor of the 1999 AAPM 
Annual Meeting tote bags.  Although most of the recruitment efforts to date have been for 
the MS Program, program administrators consider that any promotional efforts directed 
toward physics educators and the recruitment of undergraduate students will have 
positive ramifications for the residency program.  Results of program promotional 
outreach have included contacts at King College in Bristol, Tennessee, Rhodes College, 
in Memphis, Tennessee, Middle Tennessee State University in Murfreesboro, Tennessee, 
Belmont College in Nashville, Tennessee, Fisk University in Nashville, Tennessee, 
Western Kentucky in Bowling Green, Kentucky, and Kentucky Wesleyan College in 
Owensboro, Kentucky.  Future residency positions may be posted on the AAPM Jobs 
Bulletin website for widespread communication within the medical physics community.    
     
C.3   Number of Residents 
 
     At this time, the program capacity will be financially limited to one medical physics 
resident.  Program administrators hope that the program can be expanded to include two 
residents, one first-year and one second-year resident candidate.  At present, there is one 
resident in the program.  Patana Puwanich, PhD, is an international from Kohn Khen  13
University in Khon Kaen, Thailand.  He will complete his twenty-four month program on 
June 30, 2003.  Dr. Puwanich is sponsored by the Thailand government; he will return to 
Thailand in July, 2003, where he will assume the position of deputy director of the 
Medical Physics Program at Khon Kaen University.    
 
 
 
C.4     Evaluation of Resident Progress 
 
Didactic Training 
        The Program Director meets with the resident candidate at least once during each 
semester to assess resident standing in individual classes.  Resident progress (quizzes, 
homework, and examinations) is monitored by the course instructor throughout the 
semester.  Any difficulties will be discussed with the resident in a private faculty/resident 
meeting.  Should the situation warrant, the Program Director will be notified and a 
Program Director/resident meeting scheduled.  The resident is expected to obtain a 
minimum grade of ‘B’ on the courses completed.   Continued resident evaluation of 
below satisfactory could result in dismissal from the program.   
 
Clinical Training 
     The specific clinic rotation supervisor will be responsible for the resident’s evaluation 
within that rotation.  Immediate feedback of the resident’s performance will be 
determined with the application of the Vanderbilt Physics Section double-check policy.   
Monitor unit calculations, tumor doses, and treatment beam parameters will be double-
checked before the patient receives his/her first treatment.  Performance of rotation 
specific clinical duties will be supervised by the clinic rotation supervisor (or designee).  
The resident will be allowed to proceed independently with procedures and equipment 
operation after approval by the rotation supervisor.  The resident will keep a notebook of 
representative treatment plans, clinical procedures, and data for rotation specific 
assignments; the notebook will be reviewed at least semi-annually by the Program 
Director.    Should the resident’s clinical performance be less than minimally satisfactory, 
the rotation supervisor will contact the Program Director.  The Program Director, rotation 
supervisor, and the resident will have a joint meeting to discuss the resident’s 
performance.  Should remedial action be required the Program Director and rotation 
supervisor will determine the magnitude and length of time for which that specific 
training must be repeated.   Continued resident evaluation of below satisfactory could 
result in dismissal from the program. 
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C.5   New Resident Orientation 
 
          Following the arrival of a new resident on campus and prior to the beginning of 
classes and/or clinic rotations, the Program Director calls a meeting with the resident and  
representative members of the Advisory Committee to present an overview of the 
program.  Although in an informal setting, the Program Director covers three 
introductory lecture topics:  Program Administration including program resources, 
clinical and laboratory equipment, and funding; Personal and Radiation Safety Issues; 
and Career Opportunities in Medical Physics.  An outline of these lectures can be found 
in the Appendix.   The Program Director also discusses any fees structure (health 
insurance, student/resident recreation, and parking), and departmental policies and 
procedures.  The meeting format is conducive to resident discussion and interaction.  The 
resident is encouraged to maintain an open dialogue with the Program Director and the 
Advisory Committee members throughout the residency period.  At the conclusion of the 
introductory meting, the new resident is given a tour of the facilities.  During the tour, 
demonstration of the proper use of dangerous equipment (high voltage) and radiation 
emitting machines is given.  At the conclusion of the tour, the new resident is escorted to 
the Office of Environmental Health and Safety to obtain individual personnel radiation 
monitors (film badges). 
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D.1   Structure Within the Medical Center 
 
     The program is housed in the Department of Radiation Oncology at the Vanderbilt 
University Medical Center.  Didactic instruction and clinical training will be within the 
Clinical Physics Section of the Radiation Oncology Department.  Clinical physics 
policies, procedures, and administration are under the supervision of the Chief Clinical 
Physicist who is also the Program Director.  Medical policies, procedures, and 
administration are under the direction of the Chairman of the Radiation Oncology 
Department. The Vanderbilt Radiation Oncology Department has two satellite 
radiotherapy facilities located in Franklin, Tennessee, and Clarksville, Tennessee.  As 
with the Department located at Vanderbilt, the Chief Clinical Physicist (Coffey) and the 
Department Chairman (Hallahan) are responsible for physics and radiotherapy practice 
policies and procedures at the satellites. On limited occasion the resident candidate may 
be asked to participate in clinic procedures and treatment planning at the off campus 
satellite facilities. The total assigned time for a resident to attend an off-campus facility 
will be limited to less than two months during the two-year residency program.  In all 
administrative and supervisory matters, the resident will be considered an employee of 
the Department of Radiation Oncology at Vanderbilt Medical Center. 
 
 
D.2    Program Director 
  
     The Program Director is a Professor within the Department of Radiation Oncology 
and also serves as the Chief Clinical Physicist.  He is boarded in Therapeutic 
Radiological Physics by the American Board of Radiology (1977) and in Radiation 
Oncology Physics by the American Board of Medical Physics (1989). 
 
D.3    Committees and Meetings 
 
     The  Program  Director  and  members  of the Medical Physics Residency Advisory 
Committee administratively supervise and direct the residency program.  Regular 
meetings of the Advisory Committee are scheduled to assess the resident’s progress and 
clinic rotation schedule.   Direct supervision and implementation of the resident into 
clinic rotation duties is the responsibility of the rotation supervisor and the Program 
Director.  All members of the Advisory Committee except the radiation oncologist 
member are also members of the Clinical Physics Section.  Regular meetings of the 
Clinical Physics Section are scheduled to discuss clinical physics issues, work assignment  16
schedules (duty roster) administrative policies, and new technology and /or treatment 
implementation.  
 
D.4   Records Available for Review 
 
     Due to the informal nature of the past residency program activities few records are 
available for archival and review.  Resident application materials are on file and would be 
available for review by the site-visit team.   
 
E.     Resources  
 
E.1.1   List of Staff 
 
Charles W. Coffey, II, PhD.   
Professor and Chief of Clinical Physicist 
Vanderbilt Medical Center 
Radiation Oncology Department 
9.5 years with Vanderbilt 
ABR (Therapeutic Radiological Physics) and ABMP (Radiation Oncology Physics) 
70% clinical effort    
 
Dennis M. Duggan, PhD. 
Associate Professor and Clinical Medical Physicist 
Vanderbilt Medical Center 
Radiation Oncology Department 
9.5 years with Vanderbilt 
ABR (Therapeutic Radiological Physics) and ABMP (Radiation Oncology Physics) 
70% clinical effort 
 
Christopher Scarfone, PhD. 
Assistant Professor and Clinical Medical Physicist 
Vanderbilt Medical Center 
Radiation Oncology Department 
2.5 years with Vanderbilt 
passed Parts I and II of ABR (Therapeutic Radiological Physics) 
50% clinical effort 
 
Robert Aus, PhD. 
Instructor and Clinical Medical Physicist 
Vanderbilt Medical Center 
Radiation Oncology Department 
0.75 year with Vanderbilt 
80% clinical effort 
 
Wyndee Kirby, MS 
Clinical Medical Physicist 
Vanderbilt Medical Center  17
Radiation Oncology Department 
7 years with Vanderbilt 
passed Parts I and II of ABR (Therapeutic Radiological Physics) 
100% clinical effort 
 
 
 
 
 
 
Laura Butler, MS 
Clinical Medical Physicist 
Vanderbilt Medical Center 
Radiation Oncology Department 
1.0 year with Vanderbilt 
100% clinical effort 
 
Mike Beach, MS 
Clinical Medical Physicist 
Vanderbilt Ingram Cancer Center, Franklin, and Gateway Medical Center, Clarksville 
Radiation Oncology Department 
Start 05/03 with Vanderbilt Radiation Oncology Satellite Network 
100% clinical effort 
 
Patricia Thompson, RTT, CMD 
Medical Dosimetrist 
Vanderbilt Medical Center 
Radiation Oncology Department 
20 years with Vanderbilt 
100% clinical effort 
 
B.J. Proffitt, BS 
Assistant Physicist/Dosimetrist 
Vanderbilt Medical Center 
Radiation Oncology Department 
0.5 years with Vanderbilt 
50% clinical effort 
 
Wade Bullington, BS 
Assistant Physicist/Dosimetrist 
Vanderbilt Medical Center 
Radiation Oncology Department 
0.5 years with Vanderbilt 
50% clinical effort 
 
Susanne Matthews, BS 
Assistant Physicist  18
Vanderbilt Medical Center 
Radiation Oncology Department 
0.25 years with Vanderbilt 
50% clinical effort 
 
Jack Towery, BS 
Assistant Physicist 
Vanderbilt Medical Center 
Radiation Oncology Department 
0.25 years with Vanderbilt 
50% clinical effort 
 
Dennis Hallahan, MD 
Professor and Chairman 
Vanderbilt Medical Center 
Radiation Oncology Department 
5.5 years with Vanderbilt 
40% clinical effort 
 
Hak Choy, MD 
Professor and Radiation Oncologist 
Vanderbilt Medical Center 
Radiation Oncology Department 
7.5 years with Vanderbilt 
50% clinical effort 
 
Ming Teng, MD 
Assistant Professor and Radiation Oncologist 
Vanderbilt Medical Center 
Radiation Oncology Department 
6.5 years with Vanderbilt 
100% clinical effort 
 
Bapsi Chak, MD 
Assistant Professor and Radiation Oncologist 
Vanderbilt Medical Center 
Radiation Oncology Department 
5.5 years with Vanderbilt 
100% clinical effort 
 
Mike Freeman, PhD 
Associate Professor and Radiation Biologist 
Vanderbilt Medical Center 
Radiation Oncology Department 
20 years with Vanderbilt 
100% research effort  19
(Instructor for RADO 5248) 
 
 
James Patton, PhD 
Professor 
Vanderbilt Medical Center 
Radiology and Radiological Sciences Department 
30 years with Vanderbilt 
(Instructor for RAD 5313) 
 
David Pickens, PhD 
Associate Professor 
Vanderbilt Medical Center 
Radiology and Radiological Sciences Department 
22 years with Vanderbilt 
(Instructor for RAD 5313) 
 
Mike Stabin, PhD 
Assistant Professor  
Vanderbilt Medical Center 
Radiology and Radiological Sciences Department 
2.5 years with Vanderbilt 
(Instructor for RAD 5343) 
 
 
 
E.1.2   Staff Medical Physics Specialties 
 
See Appendix 
 
 
 
E.2. Financial 
 
E.2.1    Typical Resident Financial Burden to Complete Two-Year Residency 
 
Tuition:  waived (resident is considered as a non-registered participant) 
                        Books and Supplies:  $1250    
                        Resident Health Insurance:  $1800  (paid by Vanderbilt) 
                        Resident Fees:  (ie, resident recreation, parking, etc):  $750 
                        Housing, Transportation, and Food:  $28,000 
 
E.2.2   Resident Funding 
 
     Past residency funding has been through departmental clinical or development dollars 
made available by the Chairman of Radiation Oncology.  With CAMPEP residency  20
accreditation, the program will apply for federal government dollars through the Center 
for Medicare and Medicaid Services resources (Medicare Program Payment for Nursing 
and Allied Education).  Additionally the program will apply for AAPM sponsored 
residency fellowships. 
     The resident is not required to pay tuition for the didactic training (the resident is 
considered as a non-registered participant).  The residency stipend will be commensurate 
with other 1
st and 2
nd year residency salaries within the Vanderbilt Medical Center.   
Fringe benefits will be provided including FICA and health insurance. 
 
 
E.3 Facilities 
 
E.3.1    Resident Offices, Classrooms, and Conference Rooms 
 
1.  Classrooms 
A.  Physics and Chemistry Building 
B.  Nursing Building 
C.  Medical Center Complex 
a.  Radiology Department (Medical Center North) 
b.  Radiation Oncology Department (Vanderbilt Clinic) 
2.  Resident Offices 
       Radiation Oncology Dept. (Vanderbilt Clinic) 
3.  Teaching Laboratories* 
      Clinical Therapy Laboratories 
a.  Radiation Research Labs (Medical Center North) 
b.  Radiation Oncology clinical equipment (Vanderbilt 
Clinic) 
 
E.3.2.   Facilities (Academic, Laboratory, and Clinical) for Resident Use 
 
Major Equipment (Clinical) 
A.  Radiology Department (Imaging) 
a.  General Electric Discovery LS Combined dedicated PET and 
multislice x-ray CT scanner 
b.  Siemans (Computer Technology Industries) 11 MeV negative 
ion cyclotron and support facilities for FDG production 
c.  GE LX 3.0 Tesla MR scanner 
d.  GE LX 1.5 Tesla short-bore MR scanner (3) 
e.  1 Marconi MX-8000 (four slice) 
f.  2 Philips MX-8000/IDT (16 slice) 
g.  1 General Electric Light Speed Plus (8 slice) 
h.  GE Millennium VG dual-head, variable angle scintillation 
camera equipped for coincidence imaging 
i.  GE Millennium MG dual-head, variable angle scintillation 
camera for planar and SPECT imaging  21
j.  GE Helix dual-head, fixed 180 degree geometry scintillation 
camera for planar imaging 
B.  Radiation Oncology Dept. (Therapy) 
a.  Varian 21EX linear accelerator with 120 MLC collimator and 
portal imaging (2) 
b.  Varian 1800 linear accelerator for TBI and TSE 
c.  Varian 4/100 linear accelerator for radiosurgery 
d.  Varian Ximatron EX simulator 
e.  Picker 5000 QC CT/Simulator 
f.  Treatment Planning Workstations 
1.  Varian Eclipse 
2.  Varian Eclipse with Helios  
3.  ADAC Pinnacle (3) 
g.  Virtual Simulation Workstations 
1.  Varian (Soma Vision) 
2.  Picker ACQU Sim 
3.  GE Advantage Sim 
C. Major  Equipment  (Other) 
A.  Diagnostic Radiology 
a.  Radiography and fluoroscopy x-ray units 
b.  Cardiac catheterization suites 
c.  Mammography units 
d.  Ultrasound units 
B.  Radiation Oncology Brachytherapy 
a.  Varian VariSource HDR 
b.  LDR brachytherapy sources 
1.  Cs-137 (GYN) 
2.  Ir-192 (Sarcoma and GYN) 
3.  I-125 (Prostate Seed Implants) 
c.  Guidant Galileo III intravascular brachytherapy device 
C.  Radiation Biology Laboratory 
a.  Picker Eldorado 8 Cobalt-60 Unit 
b.  Pantek 300 DXT Orthovoltage x-Ray Unit 
D.  Ancillary Equipment 
A.  Radiation Detectors 
a.  Ionization Chambers 
1.  farmer-type chambers 
2.  buildup chambers 
3.  small volume specialty chambers 
4.  radiation survey meters 
b.  film and densitometers 
c.  GafChromic media and reader 
d.  Fuji Plate and reader 
e.  TLD and reader 
B.  Phantoms 
a.  Imaging physics  22
1.  GC phantoms 
2.  anthropomorphic phantoms 
b.  Therapy physics 
1.  Wellhofer WP700 water scanner 
2.  QC phantoms 
3.  anthropomorphic phantoms 
C.  Computers 
a.  Image processing workstations 
b.  Treatment planning workstations 
c.  PC computers 
 
*Notes on Resident Use of Clinical Equipment: 
A.  Resident access time on clinical equipment is limited to after clinical hours 
activities in order to maintain appropriate patient scheduled examinations and 
treatment. 
B.  Direct supervision is provided for resident use of clinical equipment.  Once 
resident has shown competence in the operation and use of equipment, the 
resident may work with only indirect supervision.   
C.  Should a problem with use or operation of clinical equipment occur during 
resident use, the resident must notify his supervisor.  The supervisor must notify 
the appropriate personnel should the equipment need maintenance or repair prior 
to clinical use the following work day. 
 
 
 
 
 
E.4.    Libraries 
 
1.  Sarah Shannon Stevenson Science Library (Physics and Chemistry Building) 
2.  Eskind Medical Library 
3.  Departmental Resource 
a.  Radiology and Radiological Sciences Dept. Library 
b.  Radiation Oncology Dept. Library 
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F.1     Safety 
 
         On the day of resident orientation, a lecture (and tour) will be given on safety issues 
within the clinical and laboratory environment of the Radiation Oncology Department. 
See Appendix for safety lecture outline. 
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G.  Program Review 
 
G.1  Summary of Strengths and Needs 
 
     The perceived strengths of the Vanderbilt Medical Physics Residency Program are 
listed below: 
1.  Administration:  The Medical Physics Residency Program is housed in the 
Department of Radiation Oncology within the School of Medicine.  The 
Program Director also serves as the Chief of Clinical Radiotherapy Physics.   
2.  Clinical Rotations/Equipment:  The Radiation Oncology Department uses 
state of the art techniques and equipment for the treatment planning and 
delivery of radiation therapy including: image fusion, 3D and IMRT 
radiotherapy, electronic portal imaging, LDR, HDR, and IVB brachytherapy. 
3.  Didactic Training:  Vanderbilt School of Medicine has an active and ongoing 
MS Medical Physics Program; the residents will be non-registered participants 
in classes offered in the MS Program. 
4.  Clinical Training:  The Physics Section of the Radiation Oncology 
Department has a proved tract record in the clinical radiotherapy physics 
training of both graduate students and post doctorate students/residents. 
 
G.2  Weaknesses of the Program include: 
1.  Number of Residents:  With the present financial resources, the Vanderbilt 
Program can only support one medical physics resident position per year.     
2.  Financial Resources:  At present the only revenue stream for support of 
medical physics residency positions is clinical and development funds from 
the Department of Radiation Oncology. 
 
G.3  Further Developments and Improvements 
 
          The Vanderbilt Medical Physics Residency Program is making development and 
improvement plans for the following goals: 
1.  Number of Residents:  With improved financial resources, the Vanderbilt 
Program would desire two residents per year, one 1
st year and one 2
nd year. 
2.  Financial Resources:  Departmental administration will seek additional 
financial support for the medical physics residency program from hospital 
clinical funds, Center for Medicare and Medicaid Services resources  25
(Medicare Program Payment for Nursing and Allied Education), and 
extramural training granting including the AAPM sponsored residency 
fellowships. 
 
 
 
 
 
 
 
H.  Appendices 
 
H.1  Letter of Invitation and Institutional Commitment 
  26
 
 
 
Documentation of Institutional Accreditation 
  27
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H.2  Vanderbilt Medical Physics Residents 
  29
Resident:  Patana Puwanich, PhD 
Date of Completion:  June 30, 2003 
Length of Time in Program: Two years (7/1/01 – 6/30/03) 
Medical Physics Specialty:  Radiotherapy Physics 
Current Status:  Deputy Director of Medical Physics Academic Program, Khon Kaen  
                          University in Khon Kaen, Thailand 
Board Certification:  not applicable 
 
Resident:  Chris Scarfone, PhD 
Date of Completion:  June 30, 2001 
Length of Time in Program: Two years (7/1/98 – 6/30/00) 
Medical Physics Specialty:  Radiotherapy Physics 
Current Status:  Assistant Professor, Department of Radiation Oncology, Vanderbilt 
                          University, Nashville, TN 
Board Certification:  passed Parts I and II, Therapeutic Radiological Physics,   
                           American Board of Radiology, will sit for the oral examination in   
                            June, 2003 
 
Resident:  Darrryl Kaurin, PhD 
Date of Completion:  April 30, 1999 
Length of Time in Program:  Two years (4/97 – 4/99) 
Medical Physics Specialty:  Radiotherapy Physics 
Current Status:  Assistant Professor, Department of Radiation Oncology, Oregon 
                          Health and Sciences University, Portland, OR 
Board Certification:  Therapeutic Radiological Physics, American Board of Radiology 
 
Resident:  Dennis Duggan, PhD 
Date of Completion:  August 30, 1994 
Length of Time in Program:  One year (8/93 – 8/94) 
                                   (Note:  Dr. Duggan spent his first in a fellowship position under  
                                     my direct supervision in the Department of Radiation Medicine 
                                     at the University of Kentucky Medical Center, in Lexington, KY 
Current Status:  Associate Professor, Department of Radiation Oncology at the  
                          Vanderbilt University Medical Center, Nashville, TN 
Certifications:   Therapeutic Radiological Physics, American Board of Radiology 
                          Radiation Oncology Physics, American Board of Medical Physics 
 
 
 
 
 
 
 
 
H.3  Clinical Therapy Physics Rotations 
  30
I.  Clinical Rotations 
1.  Simulator and CT Simulator & Observation of Patient Treatment (2wks) 
2.  External Beam Treatment Planning  (non 3D)  (4wks) 
3.  External Beam Treatment Planning  (3D)  (12wks) 
4.  External Beam Treatment Planning  (IMRT)  (12wks) 
5.  External Beam Treatment Planning  (Radiosurgery)  (6 wks) 
6.  Brachytherapy Treatment Planning  (LDR)  (6wks) 
7.  Brachytherapy Treatment Planning  (HDR)  (12 wks) 
8.  Brachytherapy Treatment Planning  (Prostate Seed Implants)  (12wks) 
9.  Brachytherapy Treatment Planning  (Intravascular Brachytherapy)  (6wks) 
10. Linear Accelerator Commissioning  (10wks) 
11. Treatment Planning Computer Commissioning  (6wks) 
12. Quality Assurance  (Linac, MLC, Superfical X-ray, & Simulator)  (6wks) 
 
 
II.  Training Objectives and Experience 
Rotation 1:  Residents will observe the immbolization and positioning  
                                      techniques necessary for conventional and CT simulation.  
                                      Residents will observe physician colleagues defining 
                                      treatment fields and outline tumor volumes and adjacent normal  
                                      tissues.  Residents will observe patient immobilization and 
                                      positioning necessary for daily radiotherapy treatment. 
 
                  Rotation 2:  Residents will learn basic treatment planning equations 
                                      for determination of monitor units and given dose  
                                      using  %DD, TAR, TMR, TPR, and off axis ratio data for  
                                      applications of single and parallel-opposed radiotherapy fields. 
                                      Residents will learn the QA associated with patient chart 
                                      data entry and record keeping.  Additionally, residents will learn       
                                      to input beam parameters into the department’s radiotherapy 
                                      record and verify computer. 
 
                  Rotation 3:  Residents will learn the principles of treatment planning including      
                                      procedures to achieve a 3D treatment plan (distribution and beam   
                                      parameters) from a patient 3D data set.  Residents will perform 
                                      hand calculations for determination of monitor units for each  
                                      treatment field; additionally, a monitor unit check program will 
                                      used to determine monitor units.  Residents will enter beam 
                                      parameter data into the record and verify computer.  Residents  
                                      learn the principles of image fusion and its applications to  
                                      3D treatment planning. 
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                  Rotation 4:  Residents will learn the principles of IMRT optimization,  
                                      treatment planning, and tumor and normal tissues dose  
                                      constraints evaluation.  Residents will independently determine 
                                      IMRT treatment field monitor units using a monitor unit check  
                                      program.  Residents will additionally participate in the                        
                                      “in vivo” quality assurance measurements of relative intensity 
                                      and absolute dose determination for each patient field. 
 
                  Rotation 5:  Residents will learn the principles of radiosurgery treatment 
                                      planning including hand calculation determination of monitor  
                                      units.  Residents will participate in daily QA procedures for 
                                      radiosurgery patient setup and treatment. 
 
                  Rotation 6:  Residents will learn the principles of brachytherapy treatment 
                                      planning optimization and point dose calculation using hand  
                                      calculation Methods (Along and Away and point source  
                                      approximation.  Residents will learn the techniques of   
                                      brachytherapy by understanding the design and use of varying 
                                      brachytherapy applicators.  Residents will participate in QA 
                                      including source activity and source preparation. 
 
                  Rotation 7:  Residents will learn the treatment planning software and  
                                      hardware associated with an HDR Ir-192 afterloader. 
                                      Residents will learn the applications of imaging based 
                                      brachytherapy including orthogonal films and 3D CT     
                                      images.  Residents will learn an independent method to 
                                      calculate HDR point dose rates.  Residents will participate 
                                      in daily, monthly, and quarterly QA procedures including 
                                      HDR source calibration determination. 
 
Rotation 8:     Residents will learn the procedures and techniques involved in  
  the treatment planning associated with permanent prostate 
  seed implants.  Residents will utilize US images for pre-implant 
                                      planning and CT images for post implant planning.  Residents 
                                      will participate in the QA procedures including source inventory 
                                      and calibration.  Residents will participant in physics 
                                      responsibilities during the brachytherapy surgery procedure.  
 
                  Rotation 9:  Residents will learn the procedures and techniques involved in 
                                      intravascular brachytherapy.  Residents will participate in daily 
                                      and monthly QA procedures including IVB source calibration 
                                      and record keeping.  Residents will participate in physics 
                                      responsibilities during the intravascular surgery procedure. 
 
                  Rotation 10:  Residents will participate in the yearly calibration of a high   
                                        energy linear accelerator.  Residents will collect beam data  32
                                        representative of data necessary for linear accelerator 
                                        commissioning and prepare a calibration report. 
 
                  Rotation 11:  Residents will learn the procedures, techniques, and beam 
                                        data analysis necessary for the commissioning of a clinical   
                                        radiotherapy beam in a treatment planning computer.  Residents  
                                        will demonstrate competence by entry of test beam data. 
                     
                  Rotation 12:  Residents will learn procedures for the routine quality  
                                        assurance of all major radiotherapy equipment including: 
                                        linear accelerator, superficial x-ray, simulator, MLC, and 
                                        portal imager.  Residents will participate in assigned QA 
                                        activities and prepare data analysis reports. 
 
 
 
III.  Clinical Conferences 
  
            1.  Weekly Patient Chart Conference 
            2.  Weekly Patient Case Presentation Conference  
                  3.  Weekly Patient Chart Check Activities 
                  4.   Monthly Physics Section Meeting 
 
 
IV.  Medical Physics Teaching Training 
 
After adequate medical physics didactic and training experience, residents 
will be given a limited teaching assignment in the didactic courses of  
medical physics that are taught in the medical radiotherapy resident and  
radiation therapist education programs.  The Program Director will  
be present at the lectures to assist and supervise the resident 
                  teaching experience. 
 
 
 
 
 
 
 
 
 
 
 
 
V.  Methods of Resident Evaluation 
  33
 Didactic Training 
        The Program Director meets with the resident candidate at least once during each 
semester to assess resident standing in individual classes.  Resident progress (quizzes, 
homework, and examinations) is monitored by the course instructor throughout the 
semester.  Any difficulties will be discussed with the resident in a private faculty/resident 
meeting.  Should the situation warrant, the Program Director will be notified and a 
Program Director/resident meeting scheduled.  The resident is expected to obtain a 
minimum grade of ‘B’ on the courses completed.   Continued resident evaluation of 
below satisfactory could result in dismissal from the program.   
 
Clinical Training 
     The specific clinic rotation supervisor will be responsible for the resident’s evaluation 
within that rotation.  Immediate feedback of the resident’s performance will be 
determined with the application of the Vanderbilt Physics Section double-check policy.   
Monitor unit calculations, tumor doses, and treatment beam parameters will be double-
checked before the patient receives his/her first treatment.  Performance of rotation 
specific clinical duties will be supervised by the clinic rotation supervisor (or designee).  
The resident will be allowed to proceed independently with procedures and equipment 
operation after approval by the rotation supervisor.  The resident will keep a notebook of 
representative treatment plans, clinical procedures, and data for rotation specific 
assignments; the notebook will be reviewed at least semi-annually by the Program 
Director.    Should the resident’s clinical performance be less than minimally satisfactory, 
the rotation supervisor will contact the Program Director.  The Program Director, rotation 
supervisor, and the resident will have a joint meeting to discuss the resident’s 
performance.  Should remedial action be required the Program Director and rotation 
supervisor will determine the magnitude and length of time for which that specific 
training must be repeated.   Continued resident evaluation of below satisfactory could 
result in dismissal from the program. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H.4  Didactic Course Titles, Content, and Instructors 
  34
RAD 210 A, B     Human Anatomy/Physiology 
 
                  Instructor:  Julie F. Hinkle 
Class consists of 3 hours/week of lecture and 1 hour/week of lab time. 
Semester Credit hours (4 hrs) 
             
M, W, F 9:10-10:00 
327 Godchaux Hall Course to be offered every year. 
 
Human Anatomy and Physiology 5
th Pkg, Elaine Nicpon Marieb (2000) 
Adam Interactive Anatomy Student Lab Guide, Mark Lafferty & Samuel 
Panella (2002) [this comes in both a pc version and a mac version, get the one 
you use]* 
Human Anatomy and Physiology Student Study Guide 5e, Elane Marieb 
(2000) *these will be packaged together in the bookstore at a discounted rate 
Rapid Review Guide, Anatomical Chart Company (isbn# 0-960-37309-8) 
Atlas of Human Anatomy, Frank H. Netter, Arthur F. Dalley (Editor) 
Paperback/Icon Learning 
 
Recommended: 
Illustation Notebook, Elaine Marieb (2002) (isbn# 0-8053-4984-7) 
 
Course Outline: 
 
Date Session  Topic 
August 28  Session 1  Introduction 
August 30  Session 2  Homeostasis 
September 2  Session 3  Cellular Chemistry 
September 4  Session 4  Cellular Chemistry II 
September 6  Session 5  Cellular Chemistry III 
September 9  Session 6  Cell Structure and Function I 
September 11  Session 7  Cellular Structure and Function II 
September 13  Session 8  Cellular Structure and Function III 
September 16  Session 9  Basic Tissues 
September 18  Session 10  Basic Tissues II 
September 20  Session 11  Integumentary System I 
September 24  Session 12  Lecture Exam I 
September 25  Session 13  Integumentary System II 
September 27  Session 14  Bone and Skeletal System I 
September 30  Session 15  Bone and Skeletal System II 
October 2  Session 16  Articulations I/Lab exam I starts tomorrow 
October 4  Session 17  Articulations II 
October 7  Session 18  Muscles and Muscle Tissue I 
October 9  Session 19  Muscles and Muscle Tissue II/Lab exam ends tomorrow 
October 11  Session 20  Muscles and Muscle Tissue III 
October 14  Session 21  Muscular System I 
October 16  Session 22  Muscular System II 
October 18  Session 23  Nervous System I 
October 23  Session 24  Lecture Exam II  35
October 25  Session 25  Nervous System II 
October 28  Session 26  Nervous System III 
October 30  Session 27  Action Potentials/Lab Exam II starts tomorrow 
November 1  Session 28  Central Nervous System I 
November 4  Session 29  Central Nervous System II/Lab Exam ends tomorrow 
November 6  Session 30  Central Nervous System III 
November 8  Session 31  Peripheral Nervous System I 
November 11  Session 32  Peripheral Nervous System II 
November 13  Session 33  Peripheral Nervous System III 
November 15  Session 34  Autonomic Nervous System I 
November 18  Session 35  Lecture Exam III 
November 20  Session 36  Autonomic Nervous System II 
December 2  Session 37  Autonomic Nervous System III/Lab Exam Starts Today 
December 4  Session 38  Neural Integration I
December 6  Session 39  Neural Integration II 
December 9  Session 40  Course Review/Lab Exam ends Today 
December 11  Session 41  Course Review 
 
 
Method of Student Evaluation: 
 
a.  Grading Policy:   
Grades for each semester of the course are calculated separately.  Plus and minus 
grades are given at the discretion of the instructor 
 
i.  Final Grade:  90-100:   A 
80-89:   B 
70-79:   C 
                              60-69:     D 
                                         Below 60:       F 
 
ii.  Exams: 
Three written exams    100 points, each 
Three laboratory exams   100 points, each 
Final written exam    200 points 
Homework     100  points 
Final Semester Grade, total Total points/8* 
 
*The lowest score on any single exam, EXCEPT THE FINAL 
WRITTEN EXAM, will be dropped in the calculation of the final 
grade. 
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RAD 5313     Clinical Diagnostic Medical Physics  
Instructor:  James Patton, David Pickens, and Mike Stabin 
Contact Hours (45 hrs) 
Semester Credit Hours (3 hrs) 
 
B.  Fall Semester, Tuesday, Thursday, 1:30-2:45 p.m., CCC-1116 MCN 
Course to be offered every year. 
 
C.  Course Outline: 
 
Date Speaker Chapt
er 
Topic 
August 29  Patton  2, 3  Introductory concepts & interactions of radiation with 
matter 
September 3  Pickens  4  Introduction to computer systems 
September 5  Pickens  5  Generation of x-rays/control of x-ray systems 
September 10  Pickens  6, 7  Projection Radiography/Film and Film processing 
September 12  Pickens  9  Fluoroscopy and Video Systems 
September 17  Riddle  8  Mammography 
September 19  Pickens  10  Image quality I 
September 24  Pickens  10  Image quality II 
September 26  Pickens    Report topic descriptions due 
October 1  Pickens    Exam I 
October 3  Pickens  11  Digital Radiography and Computed Radiography 
October 8  Pickens  13  Computed Tomography I 
October 10  Pickens  13  Computed Tomography II 
October 15  Pickens  14  Magnetic Resonance Imaging I 
October 17  Pickens  15  Magnetic Resonance Imaging II 
October 22  Pickens  16  Ultrasound 
October 24  Pickens  17  Networks, PACS, Information Systems 
October 29  Pickens    Quality Assurance of Imaging Systems 
October 31  Pickens    Exam II 
November 5  Patton  18  Nuclear Transformations 
November 7  Patton  19  Radionuclide Production and Radiopharmaceuticals 
November 12  Patton  20  Radiation Detection and Measurement 
November 14  Patton  21  Nuclear Imaging 
November 19  Patton  22  SPECT/PET 
November 21  Patton    QC of Nuclear Medicine Systems 
November 26      Thanksgiving Holiday 
November 28      Thanksgiving Holiday 
December 3  Stabin  23  Radiation Protection 
December 5  Stabin  24, 25  Dosimetry and Radiation Biology 
December 10      Reports 
December 12      Reports and Review 
December 14-19      Final Exams 
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D.  Method of Student Evaluation: 
 
I.  In-depth Report: 
An area of special interest will be selected by each student.   
Independent research of the topic will be performed leading to an in-
depth review of the area and a written report.  Resources should 
include other texts, journal articles and abstracts, and other materials 
as appropriate (internet resources, manufacturers’ information, etc.).  
The reports will be turned in at the time of a presentation of the topic 
to the class on one of the last two days of classes.  Reports are 
expected to be at least 10 pages with appropriate references.  Topics 
might include direct digital imaging systems for diagnostic or 
therapy (portal) imaging, CT angiography, functional imaging with 
emission tomography, etc.  The selected area should be written up in 
the form of single paragraph proposal for review and approval before 
beginning the research.  The instructor can offer suggestions or help 
with selection of a suitable topic. 
 
II.  Grading: 
Reports:        20% 
Exams 1 & 2:  25%, each     
Exam 3:  30% 
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RADO 5343     Radiology/Health Physics 
Instructor:  Michael Stabin 
Contact Hours (44 hrs) 
Semester Credit Hours (3 hrs) 
 
E.  Fall Semester, Tuesday, Thursday, 8:10-9:25 a.m. 
Course to be offered every year. 
 
F.  Text:  H. Cember, Introduction to Health Physics, 3
rd Edition, McGraw-Hill, 
New York, 1996 
 
G.  Course Outline: 
 
Date  Topic  Chapter 
August 29  Atomic and Nuclear Structure  3 
September 3  Radioactivity – Transformation Mechanisms  4 
September 5  Radioactivity – Transformation Kinetics  4 
September 10  Interaction of Radiation with Matter  5 
September 12  Interaction of Radiation with Matter  5 
September 17  Radiation Dosimetry  6 
September 19  Radiation Dosimetry  6 
September 24  Biological Effects of Radiation  7 
September 26  Biological Effects of Radiation  7 
October 1  History of Radiation Regulations  8 
October 3  Guidance and Regulatory Bodies  8 
October 8  Regulatory Limits  8 
October 10  TEST I  - 
October 15  Radiation Instrumentation  9 
October 17  Radiation Instrumentation  9 
October 22  Counting Statistics  9 
October 24  External Protection  10 
October 29  External Protection  10 
October 31  Internal Protection  11 
November 5  Internal Protection  11 
November 7  Radioactive Waste Management  11 
November 12  Criticality  12 
November 14  Protective Measures  13 
November 19  Protective Measures  13 
November 21  TEST II  - 
November 26  Holiday  - 
November 28  Holiday  - 
December 3  Environmental Monitoring  - 
December 5  Non-ionizing Radiation  14 
December 10  Final Exam  - 
 
*Subject to adjustment as needed 
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H.  Method of Student Evaluation: 
 
I.  Examinations and Weighting   
Test I & II:    100 points each 
                                     Final:           100 points, comprehensive 
        
II.  Quizzes: 
None are scheduled, but the instructor reserves the right to give planned and/or 
pop quizzes as deemed necessary (10 points each, as applicable). 
 
III.  Homework: 
There will be 8-12 homework sets during the semester.  Budget 3 to 4 hours per 
week on average for homework.  Al homework will be graded (5 points per set).  
Late homework will note be accepted without prior pre-approval by instructor.  
Students may work together, but each must turn in separate and unique work. 
 
IV.  Grades: 
All points count equally.  Final grades should be -350 points: exams 
(300 points) + homework (-50 points) + possible quizzes.  The final 
grade will be the total number of points obtained divided by the total 
possible.   
100-98 = A+ 
  97-93 = A 
  92-90 = A- 
  89-87 = B+ 
  86-83 = B 
  82-80 = B- 
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RADO 5248     Radiation Biology 
Instructor:  Mike Freeman, Ph.D. 
            Contact hours (30 hrs) 
Semester Credit Hours (2 hrs) 
 
I.  Fall Semester 
Course to be offered every other year 
 
J.  Text:  Radiobiology for the Radiobiologist 
Author:  E.J. Hall 
       *Supplemental information will be provided from the following text: 
    Introduction to Radiobiology by Tubiana Dutreix and Wambersie   
 
K.  Course Outline (2 lectures per topic): 
 
I.  Radiation Physics as it pertains to Radiation Biology 
A.  Electromagnetic and particulate radiation 
B.  Ionization/excitation 
C.  Stopping power, track structure, & LET 
II.  Radiation Chemistry 
A.  Radiolysis of water 
B.  Direct and indirect effects 
C.  G values 
D.  Radiolysis of DNA 
a.  Hydration effects, electron & hole transfer 
b.  Base and sugar radicals 
E.  Generation of ceramides 
III.  Formation and Repair of Damage 
A.  Formation of breaks (ssb, base, dsb, protein cross links), mutations, and  
      chromosomal damage 
B.  SLD & PLD 
C.  Repairs systems: 
a.  Genes and enzymes 
b.  Base – NER 
c.  DSB – non-homologous end joining and homologous recombination 
D.  Cell cycle check points – eg, ATM, p53, p21, etc 
E.  Signaling: eg, NFκB, ceramides, AP-1, Erg-1, etc 
F.  Oncogenes 
G.  Bystander effect 
IV.  Expression of Cell Death 
A.  apoptosis 
B.  inter-mitotic induced cell death-production of chromosomal aberrations 
C.  quantitation (survival curve analysis –target theory) 
V.  Modifiers of Radiation Damage 
A.  RBE and LET 
B.  Dose per fraction and dose rate 
C.  Chemical and physical factor – eg, oxygen, Budr, radioprotectors, 
radiosensitizers 
VI.  Radiation Effects on Normal Tissues and Organisms  41
A.  Organ sensitivity 
a.  TD-tolerance doses as a function of dose, fraction size, volume, dose 
rate, multi modalities, late effects and acute effects- predictive assays, 
cell kinectics 
B.  Morphologic patterns of radiation injury 
VII.  Radiation Effects on Tumor Tissue 
A.  Growth fractions, cell loss, cell cycle times 
B.  The 4 Rs of radiobiology 
C.  α/β model for late & acute reactions vs tumor tissures 
D.  accelerated repopulation 
E.  hyperfractionation 
F.  accelerated fractionation 
G.  Strandquist plots and NSD 
H.  TCD50 
I.  Growth Delay 
VIII.  The Role of Modalities in Radiation Therapy 
A.  Alternative modalities 
a.  Physical:  neutrons, protons, pi mesons, hyperthermia 
b.  Pharmacological: hypoxic cell sensitizers, halogenated pyrimidines, 
radioprotectors 
c.  Hyperthermia 
d.  Gene therapy 
e.  Angiogenic inhibitors 
IX.  Acutes Effects of Whole Body Irradiation 
A.  Prodromal 
B.  Cerebrovascular 
C.  Gastrointestinal 
D.  Hematopoietic 
E.  LD50 
X.  Radiation Cataractogenesis 
A.  Cataracts of the Lens 
B.  Lens opacification in experimental animals 
C.  Cataracts in humans 
D.  Degree of opacity 
E.  Latent period 
F.  Dose-response relationships 
XI.  Carcinogenesis and Non-specific Life Shortening 
A.  Definition of late effects 
B.  Carcinogenesis 
C.  Latent period 
D.  Models of carcinogenesis 
E.  Assessing risk for formation of various tumors 
F.  Malignancy in children 
G.  Molecular mechanisms of radiation induced carcinogenesis 
H.  Nonspecific life shortening 
XII.  Genetic Changes 
A.  Mutation effects in Drosophila 
B.  Mutation effects in mice 
C.  Mutation effects in human 
XIII.  Effects of Radiation on the Embryo and Fetus 
A.  Effects in developing embryo  42
B.  Experience in humans 
C.  Summary of animal and human data for teratogenesis 
D.  Malignancies associated with irradiation in utero 
E.  Occupational exposure of women of childbearing age 
F.  Pregnant or potentially pregnant patient 
XIV.  Radiation Protection:  Risk vs. Benefit 
A.  Sources of radiation to the human population 
B.  Risk 
C.  Doses from diagnostic radiology 
D.  Doses from nuclear medicine 
E.  Doses from natural background 
 
L.  Method of Student Evaluation: 
Students are required to submit 3 papers 
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RADO 5301A     Radiation Oncology Clinical Oncology Lecture Seminar  
 
Semester Credit Hours (1 hrs) 
 
Fall Semester, Friday, 8:00 a.m. 
Course to be offered every year. 
 
Handouts 
 
Lecture Schedule 
 
 
Date  Topic  Presenter 
July 11  Emergency Overview  Anthony Cmelak  
July 19  Prostate/GYN Overview  Ming Teng 
July 26  Breast Overview  Bapsi Chak 
August 2  Lung I  Hak Choy 
August 16  PEDS Overview  Ming Teng 
August 22  GI Overview  Bapsi Chak 
September 9  Breast I  Bapsi Chak 
September 16  Breast Dosimetry  Wyndee Kirby 
September 23  Breast II  Bapsi Chak 
September 30  Breast Journal Club  Bapsi Chak 
October 7  Head and Neck I  Anthony Cmelak  
October 14  Head and Neck II  Anthony Cmelak  
October 21  Head and Neck Dosimetry  Wyndee Kirby 
October 28  Head and Neck Journal Club  Anthony Cmelak 
November 4  Lung Dosimetry  Charles Coffey 
November 11  Non-Small Cell Lung Cancer  Hak Choy 
November 18  Small Cell Lung Cancer  Hak Choy 
November 25  Lung Journal Club  Hak Choy 
December 2  Cervix  Ming Teng 
December 16  Endometrium  Ming Teng 
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RADO 5304  Radiation Interactions and Dosimetry  
Instructor:  Dennis Duggan 
                  Contact Hours  (44 hrs) 
Semester Credit Hours (3 hrs) 
 
Spring Semester, Monday, Wednesday; 10:20 a.m. 
Course to be offered every year. 
 
Text:  Attix, Introduction to Radiological Physics and Radiation Dosimetry 
Wiley-Interscience, 1986 
 
Course Outline: 
 
Lecture 1  Fluence and flux; Fluence, fluence rate, flux, flux 
density, Energy fluence 
Attix, Ch. 1 
Lecture 2  Energy Transferred and Kerma; Energy transferred, 
energy fluence, energy transfer coefficient, and 
kerma; Average secondary electron energy for a 
photon beam; Radiation and collisional kerma and 
fraction of energy lost to bremsttrahlung 
Attix, Ch. 2 
Lecture 3  Exposure and Air Kerma; Relationship between 
exposure, W, and collision kerma 
Attix, Ch. 2 
Lecture 4  Absorbed Dose and Terma; Energy imparted, 
energy absorption coefficient, energy fluence and 
absorbed dose (A); Terma and the convolugiton 
integral for dose (P) 
Attix, Ch. 2 
Papanikalaou article 
Lecture 5-6  Charged Particle Equilibrium; Definition; 
Absorbed dose and collision kerma under CPE 
conditions; Exposure rate constant and absorbed 
dose from brachytherapy source; TG-43 definition 
of source strength and absorbed dose 
Attix, Ch. 4 
TG-43 Report 
Lecture 7  Transient Charged Particle Equilibrium; Definition 
of buildup, TCPE, and beta factor; Absorbed dose 
and collision kerma under TCPE conditions 
Attix Ch. 4 
Lecture 8-9  Cavity Theory; The three limiting cases: 
Small cavity, Large cavity, Medium-sized cavity; 
Bragg-Gray cavity theory:  Dose, particle fluence 
and mass stopping power ratio, Bragg-Gray 
equation and assumptions behind it 
Attix, Ch. 10 
Lecture 10  Cavity Theory; Spencer-Attix Cavity Theory; 
Assumptions in addition to those behind Bragg-
Gray equation; Spencer-Attix equation; Restricted 
mass stopping power 
Attix, Ch. 10 
Lecture 11-12  Burlin Cavity Theory; Addition assumptions; Burlin 
equation:  approximations for beta, limiting cases 
Attix, Ch. 10 
Lecture 13-14  Free Air Chamber  Attix, Ch. 12 
Lecture 15-16  Cavity Chambers; Parallel plate chambers, thimble 
chambers, saturation, recombination, polarity effect 
Attix, Ch. 12 
Lecture 17  Midterm Exam  --  45
Lecture 18-20  TG-21 Protocol; Rationale for TG-21  Attix, Ch. 13 
Med. Phys. 8, 1, 1981 
Rogers in Proceedings of 
1980 AAPM Summer 
School,  
Advanced Med. Pub., 
1990 
Shulz et al., 
Med. Phys. 10, 1, 1983 
Lecture 21-24  TG-51 Protocol; Rationale for TG-51 Protocol; 
Practical Implementation of TG-51 
Rogers in Proceedings of 
1996 AAPM Summer 
School, Advanced Med. 
Publ., 1996 
AAPM RT TG-51 
Report, AAPM Report 
#67 
Lecture 25  Thermoluminescent Dosimeters; LiF TLDs and 
Burlin Theory 
Attix, Ch. 10, 11, 14 
Lecture 26  Silicon Diodes  Attix, Ch. 16 
AAPM RT 
TG-62 Report 
Lecture 27  Silver Halide Film Dosimetry  Attix, Ch. 14 
Lecture 28  Radiochromic Film Dosimetry  AAPM RT TG-55 
Report 
AAPM Report #63 
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RADO 5311     Clinical Therapy Physics I 
Instructor:  Charles W. Coffey, II 
            Contact hours (44 hrs)     
Semester Credit Hours (3 hrs) 
 
Fall Semester, Tuesday – Thursday at 8:00 – 9:15 AM 
Course to be offered every year. 
 
Text:  Kahn The Physics of Radiation Therapy, 2
nd Edition 
Author:  F. Khan 
 
Course Outline: 
 
August 29  Ionization Chambers 
September 3  TG-51 
September 5  Superficial and Orthovoltage Machines and Calibration 
September 10  Cobalt –60 Teletherapy Units 
September 12  Linear Accelerators I 
September 17  Linear Accelerators II & New Technologies 
September 19  Treatment Planning Co-60 (%DD and TAR) 
September 24  Isocentric Treatment Planning Co-60 
September 26  EXAM I 
October 1  SAR (Irregular Fields and Off-Axis Calculations) 
October 3  Linac Treatment Planning I (%DD and TAR) 
October 8  Linac Treatment Planning II (TMR and TPR) 
October 10  Isodose Curves – Computers Treatment Planning I 
October 15  Wedges and Compensators 
October 17  Isodose Curves – Computer Treatment Planning II 
October 22  IMRT  
October 24  EXAM II 
October 29  Simulation (Techniques and Quality Assurance) 
October 31  High Energy Electron Beams I 
November 5  High Energy Electron Beams II 
November 7  Large Field Radiotherapy (Photons and Electrons) 
November 12  Linac Quality Assurance (Photons and Electrons) 
November 14  Brachytherapy I 
November 19  Brachytherapy II 
November 21  Brachytherapy III 
December 3  Brachytherapy IV (HDR & IVB) 
December 5  EXAM III 
December 10  Adjacent Photon Fields (Gapping Techniques) 
December 12  Stereoradiosurgery and Other Radiation Detectors 
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Method of Student Evaluation: 
 
I.  Examinations and Weighting  Exam I:    20% 
                                         Exam II:   20% 
                              Exam III:  20% 
                                     Final:       40% 
 
II.  Grading    A   89.5 – 100 
                 B
+   86.5 – 89.4, B 82.5 – 86.4, B
-  79.5 – 82.4 
                 C   69.5 – 79.4 
                 Failing   Below 69.4 
 
III.  Exam Policy: 
1)  Should student knowingly have a conflict prior to day of exam, 
exam must be taken before scheduled examination date. 
2)  Should student miss a scheduled exam due to illness, a make-
up exam will be given the first day that the student is able to 
return to class. 
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RADO 5312     Radiotherapy Physics II 
Instructor:  Dennis Duggan 
Contact Hours  (30 hrs) 
            Semester Credit Hours (2 hrs) 
 
Spring Semester, Tuesday, Thursday at 8:00-9:00 a.m. 
Course to be offered every year. 
 
Course Outline: 
 
Lecture 1-5   Task Group 43 System of Brachytherapy Dosimetry 
Lecture 5  Gaussian Approximation (J.D. Jackson, Classical Electrodynamics, 
John Wiley & Sons, 1998) 
Lecture 6-7  Fermi-Eyges Equation & Solution (Jette, Med. Phys. 15, 123, 1988) 
Lecture 8-10  The Hogstrom Algorithm as an Example of an Electron Pencil 
Beam Algorithm (Hogstrom et al., Phys. Med. Biol. 26, 445, 1981; 
Hogstrom in 1990 AAPM Summer School Proceedings, Advanced 
Medical Publishing, 1990 
Lecture 11  Future directions in Electron Beam Dose Calculation 
Lecture 12-13  Radiosurgery (AAPM RT TG-42 Report, AAPM Report #54) 
Lecture 14  Midterm Exam 
Lecture 15-16  Pencil Beam Models Derived from Measured Data (Storchi et al., 
Phys. Med. Biol. 41, 563, 1996; Storchi et al., Phys. Med. Biol. 43, 
1447, 1998; Storchi et al., Phys, Med. Biol. 44, 2917, 1999) 
Lecture 17-18  Convolution/Superposition Dose Calculation (Papanikolaou et al., 
Med. Phys., 20, 1327, 1993; Mackie et al., in Proceedings of 1996 
AAPM Summer School, Advanced Medical Publishing, 1996)  
Lecture 19-20  Brief Introduction to Monte Carlo Techniques (Rogers, Physics in 
Canada, 58, 63, 2002; NRC Canada Publication PIRS-702, NRC 
user Codes for EGSnrc, available by download at 
http://www.irs.inms.nrc.ca/inms/irs/EGSnrc/EGSnrc.html 
Lecture 21-22  Introduction (S. Webb, Physics of Conformal Therapy, IOP, 1997) 
Conformal Therapy, Wedges as Simplest Intensity Modulators 
Description of IMRT 
Lecture 23-28  IMRT Delivery Systems, Multileaf Collimators, IMRT Delivery 
Techniques, QA for IMRT, IMRT Treatment Planning 
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RADO 5314     Radiotherapy Physics Laboratory 
Instructor:  Charles W. Coffey, II 
            Contact hours ( 56 hrs)     
Semester Credit Hours (2 hrs) 
 
Fall Semester, Monday 1:00-5:00 p.m. 
Course to be offered every year. 
 
Course Outline: 
 
January 10  Ion Chamber Measurements & Performance Characteristics  Co-60 
January 17  Cobalt-60 Beam Parameters  Co-60 
January 24  Absolute Output, %Depth Dose and Sc/Sp  Clinac 4 
January 31  TAR and TPR  Clinac 4 
February 7  TMR, TMR0, and SMR  Clinac 4 
February 14  Superficial/Orthovoltage X-Ray Beam Parameters  X-Ray Unit 
February 21  Absolute Outputs and %Depth Dose for Electrons  Clinac 6/18 
February 28  Simulator Quality Assurance  Simulator 
March 7  SPRING BREAK  -- 
March 14  Adjacent Fields (Gapping Techniques)  Simulator/Clinac 4 
March 21  CPK Quality Assurance  Clinac 4 
March 28  Pelvis Phantom and Verification of IMRT Doses in Water  Clinac 6/18 
April 4  Total Skin Electron Dosimetry Verification  Clinac 6/10 
April 11  HDR and IVB Quality Assurance  HDR & IVB Units 
April 18  GYN Brachytherapy Dose Verification using HDR  HDR Unit 
 
Method of Student Evaluation: 
 
I.  Lab Report and Grading: 
Achievable Objectives:      5 pts 
Materials and Methods:    15 pts 
Data:         15  pts 
Data Analysis and Results:  35 pts 
Discussion and Conclusions:  25 pts 
References (2)* :      5 pts 
 
II.  Final Grade Assessment: 
Lab Reports:      80% 
Final (2 hours written exam):  20% 
 
III. Other Topics/Rules: 
1.  Lab Write-Up Deadlines: 
a.  Due at beginning of scheduled lab session 2 weeks following 
lab experiment. 
b.  20% late fee within 24 hours 
c.  30% late fee 1 day late 
d.  40% late fee 2 days late 
e.  50% late fee 3 days late 
2.  Laboratory report not submitted will receive 0 points.  50
3.  Missed labs  
a.  Missed Lab (excused) make-up available 
b.  Missed Lab (not excused) 50% late fee (lab data will be 
assigned) 
4.  General Rules 
a.  Wear Film Badge  
b.  Don’t plagiarize thy neighbor’s report 
c.  Don’t be tardy  
d.  During laboratory class, if you are not doing something 
      constructive, ask to be involved. 
*References must be copied and submitted with lab report. 
 
 
 
I. Sample Laboratory Exercise: 
Experiment #3 
 
Absolute Output, %Depth Dose, and SC/SP 
 
 
Radiation Source:  Clinac 4/100 
 
Equipment: 
1.  Working ion chamber and electrometer 
2.  Standard ion chamber and electrometer 
3.  Water phantom 
4.  Water proof sheath for ion chamber 
5.  Buildup cap for ion chamber 
6.  Solid water phantom 
7.  Clinical wedge set including 30, 45, and 60 degree wedges. 
 
 
Objectives 
1.  Determine absolute output for Clinac 4/100 at 100 cm SSD, at a depth of dmax, for 
a field size of 10 x 10, using TG#51 formalism. 
 
2.  Determine the  %DD for field sizes of 5 x 5, 8 x 8, 10 x 10, 12 x 12, 14 x 14, and 
18 x 18 for depths of dmax, 3, 5, 8, 10, 12, 15, 18 cm. 
 
3.  Determine SC,P for field sizes, 4 x 4, 6 x 6, 8 x 8, 10 x 10, 12 x 12, 16 x 16, 20 x 
20, 25 x 25, 30 x 30, and 36 x 36 at depth of dmax, in water. 
 
4.  Determine SC for field sizes, 4 x 4, 6 x 6, 8 x 8, 10 x 10, 12 x 12, 16 x 16, 20 x 20, 
25 x 25, 30 x 30, and 36 x 36 in air with buildup cap. 
 
5.  Compare %DD data with published values. 
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6.  Determine SC and SP using Khan formalism. 
 
7.  Determine beam symmetry and flatness for 4 MV x-rays for 30 x 30 field size, 
depth = 10 cm, and 100 cm SSD for transverse and radial planes. 
 
8.  Measure OCR profiles for 30 x 30 field at 100 cm SSD for depths of dmax, 5, 15, 
and 20 cm. 
 
9.  Measure wedge attenuation factors at 10 x 10 field size, depth of 10 cm (solid 
water), 100 cm SSD for 30, 45, and 60 degree wedges. 
 
10. Measure wedge attenuation factors for the 30 degree wedge atg 5 x 5 and 15 x 15 
field sizes at 100 cm SSD, for depths of dmax, 5, 10, and 15 cm (solid water). 
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H.5  Residents’ Admissions Data 
 
Patana Puwanich, PhD 
7/1/2001-6/30/2003 
PhD/Biomedical Physics, University of Aberdeen, Aberdeen, Scotland 
MS/Physics, Chulalongkorn University, Bangkok, Thailand 
 
Buxton L. Johnson, PhD 
9/1/1999-3/30/2000 
PhD/ Physics, University of Kentucky, Lexington, KY  (1994) 
MS/Physics, University of Kentucky, Lexington, KY  (1991) 
(Withdrew from program after 6 months) 
 
Christopher Scarfone, PhD 
7/1/1998-6/30/2000 
PhD/Physics, North Carolina State University, Raleigh, NC   (1998) 
MS/Physics, Cornell University, Ithaca, NY   (1991) 
 
Darryl G. Kaurin, PhD 
4/15/1997-4/15/1999 
PhD/Environmental Science, Rutgers University, New Brunswick, NJ  (1996) 
Ms/Radiological Health Sciences, Colorado State University, Fort Collins, CO  (1992) 
 
Dennis M. Duggan, PhD 
8/30/1993-7/30/1994 
PhD/Physics, University of Southern California, LosAngeles, CA  (1982) 
MS/Physics, University of Southern California, LosAngeles, CA  (1986) 53
H.6  Introductory Lectures to Incoming Students  
 
Lecture I:  Program Administration 
 
A.  Program Length, Content, and Requirements 
1.  Didactic Training 
2.  Clinical Physics Rotations 
B.  Resident Evaluations 
1.  Didactic Training 
2.  Clinical Physics Rotations 
C.  Radiotherapy Department Clinical Facilities and Equipment (including tour) 
D.  Laboratory Facilities and Equipment 
E.  Department Administration Flowchart  
F.  Financial Issues 
G.  Student ID (to be worn at all times when on campus) 
H.  Library Privileges 
I.  Grievance Procedures 
1.  Minor complaint (Instructor/Rotation Supervisor 
2.  Major complaint (Program Director and Medical Physics Residency 
Program Advisory Committee 
3.  Legal complaint (Department Chair and Associate Dean Biomedical 
Education and Research, School of Medicine 
            J.   Assignment of Office Space and Computer Passwords 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  54
 
 
Lecture II:  Personal Safety Issues 
 
A) Introduction to Radiation Safety 
a.  Tours of Radiation Facilities 
a.  Diagnostic Radiology clinical areas 
b.  Radiobiology laboratories 
c.  Radiation Oncology clinical areas 
d.  Brachytherapy source room 
b.  Time, Distance, and Shielding Concepts 
c.  Radiation Risks 
i.  Beta sources 
ii.  Gamma sources 
iii.  X-rays 
d.  Relative Radiation Doses 
i.  Diagnostic x-rays  (mrad – rad) 
ii.  Radiation therapy  (100 – 7000 rad) 
e.  Visit to DEH&S (Radiation Safety Office) 
i.  Meet the Radiation Safety Officier(s) 
ii.  Complete forms for Film Badge 
 
 
B)  Introduction to Electrical Safety 
1.   Electrical Shock (110 AC or 300 DC): equipment to include ionization   
                              chambers and electrometers 
    2.   Dangerous Electrical Safety Issues in Radiation Therapy:  equipment           
                              to include linear accelerators with voltages of 500 volts, 10,000 volts 
                              and 17,000 volts 
3.  Dangerous Electrical Safety Issues in Diagnostic Radiology:  
equipment to include high voltage transformers on x-ray machines  
and CT units 
C)   High Magnetic Fields (Safety) 
a.  Cardiac pacemakers 
b.  “Flying” magnetic materials 
c.   Watches and “magnetic-strip” cards 
D)  Other Personal Injury Risks 
1.  Lifting and carrying heavy objects and equipment 
2.  Dropping heavy objects and equipment 
3.  Cerrobend block fabrication in Radiation Oncology 
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Lecture III:  Introduction to Professions 
 
A.  Introduction to Faculty/Staff in Radiation Oncology 
B.  Introduction to Faculty/Staff in Diagnostic Radiology 
C.  Professionalism 
1.  Honesty and Vanderbilt Honor Code 
2.  Cooperation 
3.  100% Effort 
4.  Precision and Accuracy 
D.  Patient Confidentiality and Patient Privacy Issues 
E.  Career Opportunities 
1.  Practicum 
2.  Job Market 
3.  Professional Certification(s) 
F.  Junior Membership in the AAPM 
G.  Other 
1.  Security and Department Doors Interlocks 
2.  Attire 
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H.7  Faculty Biographical Sketches  
 
Charles Wade Bullington 
Biographical Sketch 
 
Job Title:    Dosimetrist 
Education:    B.S. in Physics, University of Central Arkansas, Conway, Arkansas (2000) 
Training:    On the job training in Clinical Physics Section, May. 2002 to present 
 
Board Certification/Licensure:  N/A 
Teaching Experience:  Taught undergraduate entry level physics labs for 2 years, 
 Vanderbilt University 
Clinical Experience:   Employed as Medical Physics Assistant / Dosimetrist since  
                                    May, 2002 
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CURRICULUM VITAE 
 
 
Laura E. Butler, M.S. 
Clinical Medical Physicist 
Vanderbilt University Medical Center 
 
 
EDUCATION 
1999-2002  M.S. in Medical Physics  University of Texas at 
Houston Graduate School 
of Biomedical Sciences 
     
May 1999  B.S. in Physics  University of Memphis 
  
 
HONORS AND AWARDS 
 
Recipient of Robert J. Shalek Fellowship-University of Texas M.D.Anderson 1999-2000 
 
Mu Alpha Theta Physics Award- University of Memphis, May 1999 
 
 
PUBLICATIONS 
 
“Comparison of two immobilization techniques using portal film and digitally 
reconstructed radiographs for pediatric patients with brain tumors,” Int. J. Radiat. Oncol. 
Biol. Phys. 48, 1233-1240 (2000). 
 
CLINCIAL EXPERIENCE 
 
May 2002-present  Vanderbilt University Medical Center 
  
   Monthly and Annual QA of linear accelerators, stereotactic 
radiosurgery, IMRT planning, 3D conformal treatment 
planning, HDR Brachytherapy planning 
 
 
RESEARCH  
 
2000-2002  Research Assistant, M.D. Anderson Medical Physics program 
 
1997-1998  Research Assistant, St. Jude Children’s Research Hospital, Memphis, TN 
 
  58
PRESENTATIONS 
 
Comparison of two immobilization devices for pediatric patients with brain tumors- L. 
Butler, Y. Zhu, W. Gaber, S. Samant, M. Sontag, T. Merchant. Therapy Poster, American 
Association of Physicists in Medicine 1999 Annual Conference. 
 
 
 
Dosimetric Benefits of Respiratory Gating- L.E. Butler, K.M. Forster, C.W. Stevens, S.L. 
Tucker, G. Starkschall. Therapy Poster, American Association of Physicists in Medicine 
2002 Annual Conference. 
 
 
 
PROFESSIONAL MEMBERSHIP 
 
American Association of Physicists in Medicine 
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BIOGRAPHICAL SKETCH 
    
NAME 
Chakravarthy, Anuradha  
POSITION TITLE
Assistant Professor  
EDUCATION/TRAINING
 INSTITUTION  AND  LOCATION 
DEGREE 
(If applicable)
YEAR(s)     FIELD OF STUDY 
The Johns Hopkins University, Baltimore, MD 
University of Texas Medical Branch- Galveston
B.S. 
M.D.
1974-1978 
1987
Biological Sciences 
Medicine 
Mayo Clinic, Rochester MN    1983-1986  Medicine 
The University of Maryland, Baltimore, MD    1986-1989  Oncology 
The Johns Hopkins University, Baltimore, MD    1990-1993  Radiation Oncology  
Positions and Honors 
1978 - 1978 Research Assistant, Biochemistry Research, Sinai Hospital, Baltimore, Maryland. 
1978 - 1979 Biochemistry, Harvard University, Boston, Massachusetts. 
1979 - 1980 Completed one year course work towards PhD in Biochemistry, Research Assistant,                 
         Gerontology Research Center, Baltimore, Maryland. 
1987            NCI Summer Oncology Fellowship, MCV, Richmond, Virginia. 
1979 - 1983 M.D., George Washington University, Washington, DC. 
1983 - 1986 Resident in Internal Medicine, Mayo Clinic, Rochester, Minnesota. 
1986 - 1989 Fellow in Medical Oncology, University of Maryland Cancer Ctr., Baltimore, MD. 
1989 - 1990 Instructor, Medical Oncology, University of Maryland Cancer Ctr., Baltimore, MD. 
1990 - 1993 Resident in Radiation Oncology, The Johns Hopkns University, Baltimore, MD. 
1993 - 1994 Instructor, Radiation Oncology, The Johns Hopkins University, Baltimore Maryland. 
1998 - Pres. Assistant Professor, Radiation Oncology, Vanderbilt University Medical Center, 
          Nash., TN. 
 
Selected Publications 
-Mukherjee A., Patnaik R., Bhagwan B.S. Nair P.P.  Glycoprotein Synthesis in Colonic 
Epithelial Cells from Rat Cell Biology International Reports 5:409-412, 1981. 
-Blackman M.R., Mukherjee A., Tsitouras P.D., Harman S.M.  Decreased In Vitro Secretion of 
LH, FSH and Free Alpha-Subunits by Pituitary Cells from Old Male  Rats. Am. J. Physiol.  249 
(Endocrinol. Metab., 12): E145-E151, 1985. 
-Chakravarthy A., Edwards W.D., Fleming R.  Fatal Tricuspid Valve Obstruction Due to a Large 
Infected Thrombus Attached to a Hickman Catheter. JAMA 257:801-803, 1987. 
-Heyman M.R., Chakravarthy A., Edelman B.B., Needleman S.W., Schiffer C.A. Failure of High-
Dose IV Gammaglobulin in the Treatment of Spontaneously Acquired Factor VIII Inhibitors. 
Am. J. Hematol.  28:191-194, 1988. 
-Papadimitriou J.C., Chakravarthy A., Heyman M.R.  Pseudo-Gaucher Cells Preceding the 
Appearance of Immunoblastic Lymphoma.  Am. J. Clin. Path. 90(4):454-8, 1988.  
-Chakravarthy A., Chen L.C., Mehta D., Hamburger A.W.  Modulation of Epidermal Growth 
Factor Receptors by Gamma Interferon in a Breast Cancer Cell Line.  Anticancer Research, 
11:347-352, 1991.  60
-Chakravarthy A., Pollak M., Hamburger A.W.  Interferon-Induced Modulation of  EGF-
Stimulated Growth of a Human Breast Tumor Cell Line.  J. Interferon Research 11:1-8, 1991. 
-Chakravarthy, A., Abrams, R.A. Results Following Radiation Therapy of Malignant Carcinoid. 
Cancer 75(6):1386-1390, 1995. 
-Chakravarthy A., Abrams R.A. Radiation Therapy and 5-FU in Pancreatic Cancer. Semin Radiat 
Oncol 7(4):291-99,1997. 
-Mock V., Hassey K., Meares C.J., Grimm P.M. Dienemann J.A., Haisfield M.E., Quitasol W., 
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Netherlands, 207-   216, 1996.  
4.  Coffey, C., Duggan, D., and Reddick, R.:  Dosimetric Considerations and Dose Measurement Analysis of 
Phosphorus-32 Beta-Emitting Stents: A Review.In Vascular Brachytherapy, 2
nd Edition.  Ed. R. Waksman.  Futura 
Publishing Company, Armonk, NY, 313-332, 1999. 
5.  Coffey, C. and Duggan, D.:  The Calculation and Measurement of Radiation Dose Surrounding Radioactive Stents:  
The Effects of Radionuclide Selection and Stent Design on Dosimetric Results.  3
rd Edition, Ed. R.Waksman.  Futura 
Publishing Company, Armonk, NY, 349-378, 2002. 
Patent: 
1.  Smith, S.L., Wang, P.C., and Coffey, C.W.:  Quality Control Phantom for Use In Computed Tomographic 
Imaging Instruments and Method of  Use. U.S. Patent No. 4,618,826.  October 21, 1986.                                  
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NAME 
Dennis Duggan 
POSITION TITLE
Associate Professor of Medical Physics 
 
EDUCATION/TRAINING 
INSTITUTION AND LOCATION  DEGREE 
(if applicable) 
YEAR(s) FIELD  OF  STUDY 
California State University  B.A.  1979  Physics 
University of Southern California  M.A.  1982  Physics 
University of Southern California  Ph.D.  1986  Physics 
Training: 
  1993 – 1994  Clinical Fellow, Center for Radiation Oncology, 
                         The Vanderbilt Clinic, Vanderbilt University Medical Center, Nashville, TN 
1992 – 1993  Physics Resident, Department of Radiation Medicine, University 
of Kentucky Medical Center, Lexington, KY 
Professional Experience: 
  1999 – 2002  Center for Radiation Oncology, Vanderbilt University Medical Center, Nashville, 
TN, Associate Professor, Radiation Oncology Physics 
1996 - 1999  Center for Radiation Oncology, Vanderbilt University Medical Center, Nashville, 
TN, Assistant Professor, Radiation Oncology Physics 
  1994 - 1996  Center for Radiation Oncology, Vanderbilt University Medical Center, Nashville, 
TN, Instructor, Radiation Oncology Physics 
1986 - 1992  General Atomics, San Diego, CA 
 Associate  Staff  Scientist 
1983 - 1986  University of Southern California, Los Angeles, CA 
 Research  Assistant 
1979 - 1983  Hughes Aircraft Company, El Segundo, CA 
  Member of the Technical Staff, Physics 
 
Certification: 
  Therapeutic Radiologic Physics, American Board of Radiology. 
  Radiation Oncology Physics, American Board of Medical Physics. 
 
Selected Recent and Forthcoming Publications (With names of students and trainees 
highlighted.): 
1.  C. Janicki, D.M. Duggan, D. Rahdert, “A Dose-Point-Kernel (DPK) Model for a Low 
Energy Gamma-Emitting Stent in an Heterogeneous Medium,” Med. Phys. 28, 1397 (2001). 
2.  D.M. Duggan, and B.L. Johnson, “Dosimetry of the I-Plant Model 3500 Iodine-125 
brachytherapy source,” Med. Phys. 28, 661 (2001). 
3.  D.M. Duggan, C.W. Coffey, II, J.L. Lobdell, and M.C. Schell, “Radiochromic film 
dosimetry of a high dose rate beta source for intravascular brachytherapy,” Med. Phys. 26, 
2461 (1999). 
4.  C. Janicki, D.M. Duggan, C.W. Coffey, II, and A. Gonzalez, “Dose model for a beta emitting 
stent in a realistic artery consisting of soft tissue and plaque,” Med. Phys. 26, 2451 (1999). 
5.  D.M. Duggan and C.W. Coffey, II,  “Better narrow beam profiles by exposing a stack of 
radiochromic films and averaging the readings,” Med. Phys. 26, 489-92 (1999). 
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6.  R. Nath, H. Amols, C.W. Coffey, II, D.M. Duggan, S. Jani, Z. Li, M. Schell, C. Soares, J. 
Whiting, P. Cole, I. Crocker, and R. Schwartz, “Intravascular Brachytherapy Physics: Report 
of AAPM Radiation Therapy Task Group No. 60,” Med. Phys., 26, 119-52 (1999). 
7.  D.M. Duggan and C.W. Coffey, “Small photon field dosimetry for stereotactic 
radiosurgery.”  Medical Dosimetry 23, 153 (1998). 
8.  D.M. Duggan, C.W. Coffey, II, and S. Levit, “Dose Distribution for a 32P Impregnated 
Coronary Stent: Comparison of Theoretical Calculations and Measurements with 
Radiochromic Film,”  Int. J. Radiat. Oncol. Biol. Phys., 40, 713 (1997). 
 
Books and/or Chapters: 
1.  C. W. Coffey and D.M. Duggan, “Dosimetric Considerations and Dose Measurement 
Analysis of a P-32 Radiosotope Stent.”  In Vascular Brachytherapy. Eds. Waksman, King, 
Crocker, and Mould.  Nucletron Publishing, Netherlands, 207- 216, 1996. 
2.  C. W. Coffey, D.M. Duggan, and R. Reddick, “Dosimetric Considerations and Dose 
Measurement Analysis of Phosphorus-32 Beta-Emitting Stents.”  A Review. In Vascular 
Brachytherapy, 2
nd Edition.  Ed. R. Waksman.  Futura Publishing Company, Armonk, NY, 
313-332, 1999 
3.  C.W. Coffey and D.M. Duggan, “The Calculation and Measurement of Radiation Dose 
Surrounding Radioactive Stents:  The Effects of Radionuclide Selection and Stent Design on 
Dosimetric Results.”  3
rd Edition, Ed. R. Waksman. Futura Publishing Company, Armonk, 
NY, 349-378, 2002. 
 
Research Interests: 
 
Present research interests include dosimetry of small teletherapy beams and brachytherapy, 
quality assurance for stereotactic radiosurgery, intensity modulated radiotherapy, and other types 
of conformal radiotherapy, and intravascular brachytherapy for reducing restenosis in coronary 
arteries.   
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MICHAEL LEONARD FREEMAN, Ph.D. 
 
Appointments: 
  9/89      Associate Professor with tenure: Dept. of Radiation Oncology/  Secondary Appointment: 
Associate Professor of  Radiology and Cancer Biology 
  10/86 to 12/88    Quality Assurance Director: Radiation Oncology 
  1/83 -8/89     Assistant Professor: Dept. of Radiology and Radiological Sciences 
 1979-1982    Research  Associate 
    Radiological  Research  Laboratory 
        College of Physicians and Surgeons 
    Columbia  University 
 
Education:   
  1974-1978     Ph.D. in Radiation Biology 
    Colorado  State  University 
        Advisor:  W.C. Dewey, Ph.D. 
  1972-1974     Colorado State University, B.S. Zoology 
 1970-1972    Tulane  University 
 
Areas of Research and/or Teaching Interests: 
Radiation biology, Heat Shock (Stress) Proteins, Glutathione metabolism  
 
Grants Received: 
1.  PHS grant CA-38079,  7/1/84 -  12/2005 
  PHS/NGA S10RR1 5896, Awarded 10/1/00 Therapeutic X ray Machine.   
2.  T32-093240 Training Grant in Radiation Biology,  NCI 
 7/1/02-6/30/07 
3.  Pilot Project support from P30 ES 00267, April 2000 to March 2001. 
 Pilot  Project  support  from P30 ES 00267 July 1991 to June 1992 
4.  BSRG grant 523928, awarded 9/5/88. 
5.  Young Investigator Award for the Seventh International Congress of Radiation Research, July 1983. 
6.  Young Investigator Award for the Third International Symposium, Cancer Therapy by Hyperthermia, Drugs and Radiation, 
June 1980. 
7.  P.H.S. Trainee in Radiation Biology, Colorado State University, January-August 1977.   
 
Editorial Boards 
Editorial Board  “Frontiers in Bioscience”.  2002 to present. 
Editorial Board  “Cell Stress and Chaperones” 2002 to 2005 
 
Professional Memberships: 
Radiation Research Society 
American Association for Cancer Research 
North American Hyperthermia Society 
Oxygen Society 
 
Publications: 
1.  Freeman ML, Dewey WC, Hopwood LE:  Effect of pH on hyperthermic cell killing:  Brief communication. J Natl Cancer 
Inst 58: 1837-839, 1977. 
2.  Freeman ML, Raaphorst GP, Dewey WC: The relationship of heat killing and thermal radiosensitization to the duration of 
heating at 42EC. Radiation Research 78: 172-175, 1979. 
3.  Raaphorst GP, Freeman ML, Dewey WC:  Radiosensitivity and recovery from radiation damage in cultured CHO cells 
exposed to hyperthermia at 42.5E or 45.5E.  Radiation Research 79: 390-402, 1979. 
4.  Raaphorst GP, Sapareto SA, Freeman ML, Dewey WC:  Changes in cellular heat and/or radiation sensitivity observed at 
various times after trypsinization and plating. Int J Radiat Biol 35: 193-197, 1979. 
5.  Freeman ML, Raaphorst GP, Hopwood LE, Dewey WC:  The effect of pH on cell lethality induced by hyperthermic 
treatment. Cancer 45: 2291-2300, 1980. 
6.  Dewey WC, Freeman ML:  Rationale for use of hyperthermia in cancer therapy. Annals of NY Acad of Science 335: 372-
378, 1980. 
7.  Dewey WC, Freeman ML, Raaphorst GP, Clark EP, Wong RS, Highfield DP, Spiro IJ, Tomasovic SP, Denman DL, Coss, 
RA:  Cell biology of hyperthermia and radiation.  In Radiation Biology in Cancer Research, (Meyn RE, Withers HR, 
editors). p 589-621, 1980. 
8.  Freeman ML, Holahan EV, Highfield DP, Raaphorst GP, Spiro IJ, Dewey WC: The effect of pH on hyperthermic and x-
ray induced cell killing.  Inter J Radiat Oncol Biol Phys 7: 211-216, 1981. 
9.  Freeman ML, Boone MLM, Ensley BA, and Gillette EL:  The influence of environmental pH on the interaction and repair 
of heat and radiation damage. Int J Radiat Oncol Biol Phys 7: 761-764, 1981. 
10.  Freeman ML:  The transient nature of thermotolerance. J Natl Cancer Inst Monogr. 61: 275-278, 1982.  71
11.  Freeman ML, Sierra E, Deitch AD, Cubbon RN:  The repair of potentially lethal and sublethal damage in unfed plateau 
phase cultures irradiated at 0.78 Gy/hr. Radiation Research 92: 596-603, 1982. 
12.  Goldhagen P, Freeman ML, and Hall EJ:  Studies with encapsulated 125I sources II:  Apparatus and dosimetry for 
determination of the relative biological effectiveness. Int J Radiat Oncol Biol Phys 8: 1347-1353, 1982. 
13.  Freeman ML, Goldhagen P, and Hall EJ:  Studies with encapsulated 125I sources III:  Determination of the relative 
biological effectiveness using cultured mammalian cells. Int J Radiat Oncol Biol Phys 8: 1355-1361, 1982. 
14.  Freeman ML, Sierra E, and Hall EJ:  The repair of sublethal damage in diploid human fibroblasts:  A comparison between 
human and rodent cell lines.  Radiation Research 95: 382-391, 1983. 
15.  Freeman ML, Sierra E:  An acidic extracellular environment reduces the fixation of radiation damage. Radiation Research 
97: 154-161, 1984. 
16.  Freeman ML, Malcolm AW, Meredith MJ:  Decreased intracellular glutathione concentration and increased hyperthermic 
cytotoxicity in an acid environment.Cancer Res 45: 504-508, 1985. 
17.  Freeman ML, Malcolm AW, Meredith MJ:  Glutathione pool size affects cell survival after hyperthermic treatment. Cell 
Biol and Toxicol 1: 221-231, 1985. 
18.  Freeman ML and Malcolm AW:  Acid modification of thermal damage and its relationship to nutrient availability. Inter J 
Radiat Oncol Biol Phys 11: 1823-1826, 1985. 
19.  Freeman ML, Malcolm AW, and Meredith MJ:  Role of Glutathione in Cell Survival after Hyperthermic Treatment of 
Chinese Hamster Ovary Cells. Cancer Research 45: 6308-6313, 1985. 
20.  Freeman ML, Scidmore NC, Malcolm AW, and Meredith MJ:  Diamide exposure, thermal resistance and synthesis of 
stress (heat shock) proteins. Biochem Pharm 36: 21-29, 1987. 
21.  Freeman ML, and Meredith MJ:  The effect of GSH depletion on thermal radiosensitization.  Int J Radiat Oncol Biol Phys. 
13: 1371-1375, 1987.   
22.  Freeman, ML, Scidmore NC, Meredith MJ:  Inhibition of heat shock protein synthesis and thermotolerance by 
cycloheximide. Radiat. Res. 112: 564-574, 1987. 
23.  Freeman,ML and Meredith, MJ:  Subcellular localization of glutathione and thermal sensitivity. Radiation Res.  115:461-
471,1988. 
24.  Freeman, ML, Meredith, MJ, and Laszlo, A:  Depletion of glutathione during HSP synthesis and the development of 
thermotolerance. Cancer Res. 48:7033-7037, 1988. 
25.  Freeman, ML and Meredith, MJ:  Measurement of protein thiols after heat shock using 3-(-N-maleimido-propionyl) 
biocytin labeled proteins separated by SDS-PAGE and electroluted onto nitrocellulose:  Thiol Blotting.  Radiation Res. 
117: 326-333,1989. 
26.  Freeman, ML and Meredith, MJ:  Glutathione conjugation and induction  of a 32,000 dalton stress protein. Biochem. 
Pharmacol  38:299-304, 1989.    
27.  Freeman, ML and Meredith, MJ:  Modulation of diamide toxicity in thermotolerant cells by inhibition of protein synthesis. 
Cancer Res. 49: 4493-4498, 1989. 
28.  Atsmon J, Freeman ML, Meredith MJ, Sweetman BJ, and Roberts LJ. Enhancement of 9 Deoxy >
9,>
12- PGD2 
antiproliferative effect by glutathione depletion.  Cancer Research 50:1879-1885,1990. 
29.  Freeman ML, Meredith MJ, and Eisert DR.  Failure of chronic glutathione elevation to reduce cytotoxicity produced by 
exposure to cis diamminedichloroplatinum (II), ionizing radiation, or hyperthermia.  Cancer Res. 50: 5296-5300, 1990. 
30.  Freeman ML, Spitz DR, and Meredith MJ, Does heat shock promote oxidative stress?  Studies with ferrous and ferric iron.  
Radiat. Res. 288-293, 1990. 
31.  Saunders EL, Meredith MJ, Eisert DR, and Freeman ML, Depletion of glutathione after (-irradiation modifies survival.  
Radiation Res. 125: 267-276, 1991. 
 32.  Saunders EL, Maines MD, Meredith MJ, and Freeman ML, Enhancement of heme oxygenase-1 synthesis by glutathione 
depletion in Chinese hamster ovary cells.  Arch. Biochem. Biophys. 288: 368-373, 1991. 
33.  Atsom J, Freeman ML, Meredith MJ, Sweetman BJ, Roberts LJ 2
nd, Modulation of the antiproliferative activity of 9-
deoxy-delta 9, delta 12(E)-PGD2 by conjugation with intracellular glutathione.  Adv. Prostaglandin Thromboxame 
Leukotriene  Res.  21B: 887-890, 1991. 
34.  Sierra-Rivera E, Voorhees GJ and Freeman ML,    (-irradiation increases HSP 70 in Chinese hamster ovary cells. 
Radiation Res. 135: 40-45, 1993. 
35.  Freeman ML, Sierra-Rivera E, Voorhees GJ, Eisert DR, and Meredith MJ, Synthesis of HSP 70 is enhanced in GSH 
depleted Hep G2 cells, Radiation Res. 135: 387-393, 1993. 
36.  Sierra-Rivera E, Meredith MJ, Voorhees, GJ, Oberley LW, Eisert SR, and Freeman ML, The synthesis of heat shock 
proteins following oxidative challenge: The role of glutathione. Inter. J. Hyperthermia 10: 573-586, 1994. 
37.  Sierra-Rivera E, Meredith MJ, Summar, ML, Smith MD, Voorhees GJ, Stoffel CM, and Freeman, ML, Genes regulating 
glutathione concentrations in x-ray transformed rat embryo fibroblasts: Changes in  (-glutamylcysteine synthetase and (-
glutamyl transpeptidase expression. Carcinogenesis 15: 1301-1307, 1994. 
38.  Freeman ML, Borrelli MJ, Syed K, Senisterra G, Stafford DM, and Lepock JR. Characterization of a signal generated by 
oxidation of protein thiols that activates the heat shock transcription factor.  J. Cell. Physiol. 164: 356-366, 1995 
39.  Sierra-Rivera E, Summar ML, Krishnamani MRS, Phillips III JA, and Freeman ML. Assignment of the gene that codes the 
heavy subunit of (-glutamylcysteine synthetase to human chromosome 6. Cytogenetics and Cell Genetics 70: 278-279, 
1995. 
40.  Sierra-Rivera E, Dasouki M, Summar ML, Krishnamani MRS, Meredith M, Rao PN, Phillips JA, and Freeman ML, 
Chromosomal localization of the human gene that encodes the regulatory  subunit of (-glutamylcysteine synthetase to 
chromosome 1p21.  Cytogenetics and Cell Genetics 72: 252-254, 1996. 
41.  McDuffee AT, Senisterra GA, Huntley SA, Lepock JR, Senkhar KR, Morrow JD, and Freeman ML, Proteins conctaining 
non-native disulfide bonds generated by oxidative stress may act as signals for the induction of the heat shock response. J. 
Cellular Physiology 171: 143-151, 1997 
42.  Sekhar KR, Long M, Long, J, Xu ZQ, Summar, ML, and Freeman, ML, Alteration of transcriptional and post-
transcriptional expression of (-glutamylcysteine synthetase by diethyl maleate. Radiation Res. 147: 592-597, 1997  72
43.  Oikawa T, Freeman ML, Lo W, Vaughan DE, and Fogo A, Modulation of plasminogen activator inhibitor-1(PAI-1) in 
vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Inter. 51: 164-172, 1997 
44.  Sekhar KR, Meredith MJ, Kerr KD, Soltaninassab SR, Spitz DR, Xu ZQ, and Freeman ML, Expression of glutathione and 
(-glutamylcysteine synthetase mRNA is Jun dependent. BBRC 234: 588-593, 1997.  
45.  Freeman ML, Huntely SA, Meredith MJ, Senisterra GA, and Lepock JR, Destabilization and denaturation of cellular 
protein by glutathione depletion. Cell Stress and Chaperones, 2: 191-198, 1997. 
46.  Senisterra GA, Huntley SA, Escaravage M,  Sekhar KR, Freeman ML, Borrelli M, and Lepock JR, Destabilization of the 
Ca
2+-ATPase of Sarcoplasmic reticulum by thiol specific-specific, heat shock inducers results in thermal denaturation at 
37EC. Biochemistry 36: 11002-11011, 1997. 
47.  Brown KE, Kinter MT, Oberley TD, Freeman ML, Frierson HF, Ridnour LA, Tao Y, Oberley LW, and Spitz DR. 
Enhanced (-glutamyl transpeptidase expression and selective loss of CuZn superoxide dismutase in hepatic iron overload. 
Free Radical Biology and Medicine 24: 545-555, 1998. 
48.  Abbott DW, Freeman ML, and Holt JT, Double_Strand Break Repair Deficiency and Radiation Sensitivity in BRCA2 
Mutant Cancer Cells.  JNCI 90: 978-985, 1998. 
49.  Borrelli MJ, Stafford DM, Rausch CM, Freeman ML, Lepock JR, and Corry PM, Diamide induced cytoxicity and 
thermotolerance in CHO cells. J. Cell. Physiol. 177: 483-492, 1998. 
50.  Meredith MJ, Cusick CL, Soltaninassab S,  Sekhar KS, Lu S and Freeman ML, Expression of Bcl-2 increases intracellular 
glutathione by inhibiting methionine dependent GSH efflux. BBRC 248: 458-463, 1998. 
51.  Sekhar KR and Freeman ML, Autophosphorylation inhibits the activity of gamma- glutamylcysteine synthetase.  J. 
Enzyme Inhibition.   14: 323-330, 1999. 
52  Amorino G, Freeman ML, Carbone DP, Lebwohl DE, and Choy H, Radioprotection by the oral platinum agent, JM216: 
Role of repair inhibition.  Inter. J. Radiation Oncology, Biology, Physics. 44:399-405, 1999. 
53.   Soltaninassab SR, Sekhar KR, Meredith ML, and Freeman ML,   Multi-faceted regulation of gamma glutamylcysteine 
synthetase.  J. Cell Physiol. 182: 163-170, 2000. 
54.   Amorino GP, Freeman ML, Choy H:  Enhancement of radiation effects by the estrogen metabolite 2-methoxyestradiol.  
Radiation Research, 153: 384-391, 2000 
55.  Brown NJ, Nakamura S, Ma LJ, Nakamura I, Donnert E, Freeman M, Vaughan DE, and Fogo AB, Aldosterone modulates 
plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int.  58:1219_1227, 2000. 
56.  Sekhar KR,Soltaninassab SR, Borrelli MJ, Xu ZQ, Meredith MJ, Domann FE, and Freeman ML, Inhibition of the 26S 
proteasome induces expression of GLCLC, the Catalytic Subunit for  (-Glutamylcysteine Synthetase. BBRC 270: 311-317, 
2000. 
57.  GA Senisterra, HE Frey,  ML Freeman, MJ Borrelli, and JR Lepock, Protein destabilization and denaturation: Implications 
for hyperthermia and the heat shock response. Recent. Res. Devel. Biochem. 2: 65-96, 2000. 
58.  KR. Sekhar,  DR. Spitz, S Harris, TT. Nguyen, M J. Meredith, JT. Holt, D Guis, LJ. Marnett, ML. Summar and ML. 
Freeman.  Redox Sensitive Interaction Between KIAA0132 and Nrf2 Mediates Indomethacin-Induced Expression of γ-
Glutamylcysteine Synthetase.   Free Radical Biology and Medicine.  32: 650-662, 2002. 
 
59.  MJ Borrelli, LJ  Bernock, J Landry, DR Spitz, LA Weber, E Hickey, M L. Freeman, and PM. Corry, Stress protection by a 
fluorescent HSP_27 chimera that is independent of nuclear translocation or multimeric dissociation. In Press Cell Stress 
and Chaperones. 
60.   K. R. Sekhar, X. Yan, and M. L. Freeman, Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by 
KIAA0132, the human homolog to INrf2.  Oncogene.21:6829-6834, 2002 
61.   AS Willis, ML Freeman, SR Summar, SM Williams, E Dawson, and ML Summar. Ethnic diversity in a critical gene 
responsible for glutathione synthesis.  In Press Free Radical Biology and Medicine.   
 
Community service: 
Firefighter/engineer - Bellevue Volunteer Fire Department, Nashville, TN  1984 -1989 
Training Officer - Bellevue Volunteer Fire Department, Nashville, TN 1987 - 1988. 
Training Officer - Pegram Fire Department, Pegram, TN  Dec. 1990 to Dec. 1992 
Assistant Pack Master for Cub Scout Pack 21, Nashville Tn 1989-1990 
Pack Master for Cub Scout Pack 21, Nashville TN 1990 to 1991 
Den leader, Cub Scout Pack 21 1990 to 1991 
Den Leader, Cub Scout Pack 21 1994-1995. 
Mentor for:  NC Scidmore,    Medical Student   2 papers 
    J. Atsmon, M.D.        Visiting Scientist  2 papers 
    EL Saunder M.D.        Resident    2 papers 
    CM Stoffel    Medical Student  1 paper & 1 Book review 
    E Sierra-Rivera, Ph.D.  Post Doc.    5 papers 
    GJ Voorhees, M.D.      Instructor    3 papers 
  MD  Smith,  M.D.       Instructor   1  paper 
    M Murray, M.D.    Instructor    1 Invited Book Chapter 
    AT McDuffee, M.D.    Fellow in Pediatrics    1 paper 
    KR Konjeti, Ph.D.    Instructor    2 papers &1 Invited Review 
    SR Soltaninassab, Ph.D.  Post Doc    2 papers 
    G, Amono     Post Doc    2 papers 
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NAME 
Dennis E. Hallahan 
POSITION TITLE
Professor and Chairman  
EDUCATION/TRAINING 
INSTITUTION AND LOCATION  DEGREE 
(if applicable) 
YEAR(s) FIELD  OF  STUDY 
University of Illinois, Chicago  B.S.  1980  Biology 
Rush Medical College, Chicago  M.D.  1984  Medicine 
Professional Experience 
1984-86 Intern and Resident, Internal Medicine, University of Chicago, Chicago 
1986-90  Resident, Radiation Oncology, University of Chicago, IL 
1988-90  Molec. Biol. And Rad. Biol., Radiation Oncology, University of Chicago 
1990-94  Assistant Professor, Dept Radiation and Cellular Oncology, University of Chicago 
1994-97  Associate Professor, Dept Radiation and Cellular Oncology, University of Chicago 
1998-present  Professor and Chairman, Dept Radiation Oncology, Vanderbilt University     
1998-present Professor,  Dept  Biomedical Engineering, Vanderbilt University 
 
Research Projects Ongoing or Completed During the Last 3 Years: 
“X-ray-guided drug delivery” 
Principal Investigator: Dennis E. Hallahan, Agency: NIH/NCI, Type: R01 (CA88076-01), Period: 2002-
2007 
"Flk1 Signaling Protects Tumor Vasculature from Radiation" 
Principal Investigator: Dennis Hallahan, Agency:  NIH/NCI, Type: 1 R01 CA89674-01, Period: 2001 -
2005  
The objective of this study is to study the mechanisms by which tumor blood vessels respond to ionizing 
radiation.  The general hypothesis is that the FLK-1 receptor mediates resistance of tumor blood vessels to 
the cytotoxic effects of radiation and participates in repair of radiation-induced injury in tumor blood 
vessels. 
“X-Ray-guided drug delivery by apcitide- 
99Tc” 
Principal Investigator: Dennis E. Hallahan, Agency: NIH/NCI, Type: R21 (CA89888-01), Period: 2000-
2002 
The objective of this clinical study is to determine the threshold dose and tumor types which radiation 
activates receptors for drug delivery.  We are utilizing a peptide that binds to radiation activated receptors.  
The 
99Tc localizes to tumors treated with radiation.  This is the prototype for radiation-guided drug 
delivery. 
“X-rays Induce Exocytosis of Endothelial P-selectin” 
Principal Investigator: Dennis E. Hallahan, Agency: NIH/NCI, Type: 2-R01 (CA58508), Period: 1998-
2003 
The objective of this study is to determine the mechanisms by which ionizing radiation activates exocytosis 
of storage reservoirs from the endothelium.  The components of these storage reservoirs include 
biologically active molecules.  The  
mechanisms of radiation induced exocytosis include microtubule-dependent transport.  The signaling 
pathway and mechanisms of transport will be studied. 
“Cancer Center Support Grant” 
Principal Investigator: Harold Moses, Agency: NIH/NCI, Type: 2-P30 (CA68485-04), Period: 1999-2004 
This staff investigator grant supports the percent effort in the Cancer Center.  This funding is provided for 
leadership in the Radiation Biology and Radiation Oncology programs within the Vanderbilt Cancer 
Center. 
“Lung Cancer SPORE” 
Principal Investigator: David Carbone, Agency:  NIH/NCI, Type:  P50 CA90949, Period:  4/01/01-3/31/06 
Clinical trial of SU5416 and radiation in lung cancer patients. 
“Induction of Cell Adhesion Molecules by Ionizing Radiation” 
Principal Investigator: Dennis E. Hallahan, Agency: NIH/NCI, Type: R01 (CA70937), Period: 1998-2001 
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This study examined the mechanisms of transcriptional activation of ICAM-1 and E-selectin in the vascular 
endothelium.  
 
Publications (selected from over 100) 
1.  Hallahan, D.E., Varudachalam, S., Schartz, J.L., Panje, N., Mustafi, R., and Weichselbaum, R.R.  
Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation.  Radiat. Res. 129:345-
350, 1992. 
2.  Weichselbaum, R.R., Hallahan, D.E., Sukhatme, V.P., and Kufe, D.W.  Gene therapy targeted by 
ionizing radiation. International Journal of Radiation Oncology Biology Physics 24:565-567, 1992. 
3.  Hallahan, D.E., Gius, D., Kuchibhotla, J., Sukhatme, V., Kufe, D.W., and Weichselbaum, R.R.  
Radiation signaling mediated by Jun activation following dissociation from a cell specific repressor. J. 
Biol. Chem. 268:4903-4907, 1993. 
4.  Hallahan, D.E., Varudachalam, S., Kuchibhotla, J., Kufe, D.W., and Weichselbaum, R.R.  Membrane-
derived second messenger regulates x-ray-mediated TNF alpha gene induction. Proc. Natl. Acad. Sci. 
91:4897-4901, 1994. 
5.  Hallahan, D.E., Virudachalam, S., Kufe, D.W., and Weichselbaum, R.R.  Ketoconazole attenuates 
radiation-induction of tumor necrosis factor. Int. J. Radiat. Oncol. Biol. Phys. 29:777-780, 1994. 
6.  Weichselbaum, R.R., Hallahan, D.E., Beckett, M.A, Mauceri, H.J., Lee, H., Sukhatme, V.P., and Kufe, 
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 01/1993-04/1993  CHEMLABS  Brentwood, TN 
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1972-1973:  Research Associate, Division of Nuclear Medicine & Biophysics, Vanderbilt 
Univ, Nash, TN 
1972-1973:   Research Associate, Department of Biomedical Eng., Vanderbilt University, 
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1979-1988:  Associate Professor of Radiology, Vanderbilt University, Nashville, TN 
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2.  Delbeke D, Videlefsky S, Patton JA, Campbell MG, Martin WH, Ohana I, Sandler MP.  Rest 
Myocardial Perfusion/Metabolism Imaging Using Simultaneous Dual Isotope Acquisition 
SPECT with 
99mTc-MIBI/
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5.  Martin WH, Delbeke D, Patton JA, Sandler MP.  FDG SPECT vs. FDG PET for the 
Detection of Malignancies.  Radiology 198:225-231, 1996. 
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1996-Present: Associate Professor of Biomedical Engineering, Vanderbilt University, 
Nashville, TN 
1992-Present:  Associate Professor of Radiology, Vanderbilt University, Nashville, TN 
 
Other Experience and Professional Memberships: 
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Blood Flow in IBS and Controls with Painful and Non-Painful Rectal Distention. 
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21.  Morgan VL, Pickens DR, Hartmann SL, Price RR.  Comparison of functional MRI 
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During Braille Reading is Influenced by Early Visual Experience in Subjects with Severe 
Visual Disability: A Correlation fMRI Study.  Human Brain Mapping, 2001; 14:186-195. 
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Multidisciplinary Research Training in Cancer Imaging   
 The goal of this project is to establish a unique training program in cancer imaging research.  
The program is designed to train both medical post-doctoral candidates and basic-science post-
doctoral candidates.   
 Role:  Preceptor 
 
Completed Research Support 
BES-880834    Price  (PI)       08/15/98-08/14/00 
NSF 
Position Tracking for Motion Correction in MRI 
The goal of this project is to develop and demonstrate a system whereby the motion of a 
subject/patient undergoing a magnetic resonance imaging (MRI) examination is monitored in 
near realtime and the information is fed back to the MRI scanner to produce “motion-free” 
images. 
Role:  Investigator 
 
5R21 DK57047-02    Mertz (PI) 
Regional Cerebral Activation with Visceral Pain in IBS and Controls 
The goal of this project is to investigate cerebral pain response in Irritable Bowel Syndrome with 
and without pharmaceutical interaction. 
Role:  Investigator 
 
Industry-Pharmaceutical    Price (PI)          05/01/98-06/30/99 
Evaluation of the Varian Amorphous Silicon (aSi) Sensor 
To determine the optimum radiographic technique for selected clinical procedures to be used with 
Varian aSi sensor and to evaluate image quality relative to conventional film/screen systems. 
Role:  Investigator 
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James Benjamin (BJ) Proffitt 
Biographical Sketch 
 
 
Job Title:  Dosimetrist 
 
Education:  B.S. in Physics from Belmont University in Nashville, TN  (2002) 
 
Training:  On the job training from April ’02 to present at Vanderbilt University 
 
Board Certification or Licensure:  none 
 
Teaching Experience:  none 
 
Clinical Experience:  Working in dosimetry for 1 year (April ’02 – present 86
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NAME 
Christopher Scarfone 
POSITION TITLE 
Assistant Professor and Medical Physicist 
EDUCATION/TRAINING 
INSTITUTION AND LOCATION  DEGREE 
(if applicable) 
YEAR(s) FIELD  OF  STUDY 
University of Vermont, Burlington, Vermont  B.S.  1988  Physics 
Cornell University, Ithaca, NY  M.S.  1991  Physics 
University of North Carolina at North Carolina State, 
Raleigh, NC 
Ph.D.  1998  Physics 
 
Professional Experience and Appointments: 
1987    Research Trainee, Stanford University, Stanford Linear Accelerator Center, Stanford, CA  
1988-1991 Teaching  Assistant,  Cornell  University, Department of Physics, Ithaca, NY 
1992-1993  Lecturer, University of Vermont, Department of Physics, Burlington, VT  
1993-1998  Research Assistant, Duke University Medical Center, Department of Radiology, Durham, 
NC  
1995-1998  Research Assistant, Duke University Medical Center, Department of Radiation 
Oncology, Durham, NC  
1995-1998  Staff Physicist, Data Spectrum Corporation, Hillsborough, NC  
1998-05/2000 Medical  Physics  Resident, Vanderbilt University Medical Center, Department of 
Radiation Oncology, Nashville, TN  
05/2000-2001  Instructor and Medical Physicist, Vanderbilt University Medical Center, Department of 
Radiation Oncology, Nashville, TN  
05/2000-2001  Instructor (joint appt.), Vanderbilt University Medical Center, Department of Radiology 
and Radiological Sciences, Nashville, TN  
07/2001-Pres  Assistant Professor and Medical Physicist, Vanderbilt University Medical Center, 
Departments of Radiation Oncology, Nashville, TN  
07/2001-Pres  Assistant Professor (joint appt.), Vanderbilt University Medical Center, Department of 
Radiology and Radiological Sciences, Nashville, TN  
Academic Honors and Awards: 
1985    Charles G. Fraiser Award for Physics, University of Vermont  
1987    Phi Beta Kappa - University of Vermont  
1987    David W. Juenker Award for Physics, University of Vermont  
1988    Magna Cum Laude – University of Vermont  
1988-1991  Tuition Fellowship, Department of Physics, Cornell University    
1997  American Cancer Society Institutional Research Grant Student Award Nominee - Duke 
University Medical Center  
1999    Winner, Vanderbilt-Ingram Cancer Center Retreat Poster Competition  
National Award: 
1998-2000  American Society of Therapeutic Radiation Oncologists (ASTRO) Clinical Radiotherapy 
Physics Resident Award  
Invited Speaker: 
June 2000  Functional Treatment Planning, 25
th Annual Meeting of the American Association of 
Medical Dosimetrists (AAMD), Portland, OR  
Government Funding and Grant Writing Experience: 
1.  The Use of Fan-Beam SPECT for Breast Tumor Detection, National Institutes of Health - Breast 
Imaging Group, Duke University Medical Center, (Funded 1995-1997) 
2.  Dynamic Cardiac Phantom for Nuclear Medicine Imaging, National Institutes of Health, Small 
Business Innovation Research (SBIR) Grant, Data Spectrum Corporation, (Phase I Funded 1996-1997) 
Research Projects Ongoing or Completed During the Last Three Years:  
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1.  “Flk1 Signaling Protects Tumor Vasculature from Radiation”, (Study the mechanisms by which tumor 
blood vessels respond to ionizing radiation) 
Principal Investigator: Dennis E. Hallahan, M.D. 
Agency:  National Cancer Institute  
Type:  RO1 (CA89674-01) Period: 2001-2005. 
Role on project: Development and implementation of quantitative molecular imaging techniques. 
2.  “X-ray Guided drug delivery by apcitide-99mTc”, (Determination of the threshold dose and tumor 
types and which radiation activates receptors for drug delivery) 
Principal Investigator: Dennis E. Hallahan, M.D. 
Agency:  National Cancer Institute 
Type: R21 (CA89888-01) 
Role on project: Quantitative and qualitative analysis of peptide distributions using SPECT. 
 
BOARD CERTIFICATION: 
American Board of Radiology - Therapeutic Radiologic Physics, Written exam Parts I and II Passed. 
Part III (oral exam) scheduled for June 2003 in Louisville, KY. 
PROFESSIONAL MEMBERSHIPS AND COMMITTEES: 
Full Member - American Association of Physicists in Medicine (AAPM) 
Full Member - Society of Nuclear Medicine (SNM) 
Co-founder and core member – AAPM Science Council Committee: Molecular Imaging in Clinical 
Radiation Oncology (MICRO) 
Member – AAPM Science Council Committee: Nuclear Medicine 
UNIVERSITY COMMITTEES: 
Member – Radiology Grants Committee 
Member – Quantitative Nuclear Medicine Committee 
Professional Activities: 
Reviewer   The Journal of Nuclear Medicine, 1998-present 
   Cancer Biotherapy and Radiopharmaceuticals, 2002-present 
Teaching Activities: 
2001-Pres   Radiological Physics, Lecturer, Vanderbilt Center for Radiation Oncology Program in 
Radiation Therapy 
2000-Pres   Therapy Physics Laboratory, Laboratory Assistant, Vanderbilt Department of Radiation 
Oncology Masters degree program in Medical Physics 
Fall 2002    The Physics of Radiology, Physics 228 - Department of Physics, Vanderbilt University, 
Student and Fellow Supervision: 
1.  Philip Haberlen, B.S., Candidate for degree of Medical Doctor, Vanderbilt University School of 
Medicine,  Combination SPECT/CT Imaging Provides a Cost-Effective Alternative to Dedicated 
SPECT and CT Imaging, Introduction to Biomedical Research meeting presentation, Spring 2001. 
2.  Alisha Smith, B.S., Certified Nuclear Medicine Technician Program, Vanderbilt University School of 
Medicine, First Generation Radiation Guided Therapy for Brain Tumors, Tennessee Sate Nuclear 
Medicine Meeting, Pigeon Forge, TN, Spring 2001. 
3.  Barth Lynch, undergrad, University of Tennessee.  REU student through Biomedical Engineering 
Department at Vanderbilt.  Project:  IMRT Film QA, (Summer 2001). 
4.  Mark D. Anderson, undergrad, University of Miami, Florida.  REU student through Biomedical 
Engineering Department at Vanderbilt.  Project:  IMRT Film / Treatment Plan Overlay Techniques, 
(Summer 2002). 
5.  William “Rusty” Lavely, M.D., Imaging Research Fellow, Department of Radiology and Radiological 
Sciences.  Project:  Multiple Image Modality Treatment Planning, (January 2002-present). 
6.  Kenneth Niermann, M.D., Imaging Research Fellow, Department of Radiology and Radiological 
Sciences.  Project:  High-Field Magnetic Resonance Spectroscopy with Applications to Radiation 
Treatment Planning,  (July 2002-present).  
Publications: 
1.  Scarfone, C., Cmelak, A.J., Delbeke, D., Lavely, III, W., Martin, W., and Hallahan, D.E., 
Radiotherapy target volumes for head and neck cancer: a comparison of x-ray CT and PET, (in 
preparation).  88
2.  Scarfone, C., Cmelak, A.J., Delbeke, D., Lavely, III, W., Martin, W., and Hallahan, D.E., Influence of 
PET image reconstruction technique on radiotherapy target volumes, (in preparation). 
3.  Hallahan, D.E., Qu, S.M., Geng, L., Cmelak, A., Chakravarthy, A., T., Martin, W., Scarfone, C., and 
Giorgio, T., Radiation-mediated control of drug delivery, Am J Clinical Onc-Cancer Clinical Trials, 
24(5), 473-480, Oct. 2001. 
4.  Hallahan, D.E., Geng, L., Cmelak, A.J., Chakravarthy, A.B., Martin, W., Scarfone, C., and Gonzalez, 
A., Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature, J Cont Rel, 74 
(1-3), 183-191 (2001). 
5.  Scarfone, C., Patton, J.A., Cmelak, A.J., and Sandler, M.P., Gamma camera-based PET inverse 
treatment planning for head and neck cancer using hybrid imaging istrumentation and imrt, in The 
Scintillating Future of Nuclear Medicine, T. Nishimura, H.W. Strauss and M. Fukuchi, Eds., (in print 
May 2001). 
6.  Scarfone, C., A transition to clinical medical physics, to appear in The Society of Physics Students 
Newsletter, American Institute of Physics, pubs., (Spring 2001). 
7.  Scarfone, C., Marks, L.B., Munley, M.T., Jaszczak, R.J., and Coleman, R.E., Influence of single 
photon emission computed tomography (SPECT) reconstruction technique on pulmonary dose-
response curves: a phantom and patient study, Int J Rad Onc Biol Phys (in preparation). 
8.  Scarfone, C., and Coffey, C.W., II, Nuclear medicine imaging for external beam cancer treatment: an 
overview for the clinical medical physicist, American College of Medical Physics Annual Meeting, 
Whistler Resort, British Columbia, CA (May 2000). 
9.  Scarfone, C., Morgan, V., Rohde, G.K., Patton, J.A., and Sandler, M.P., Combined functional and 
anatomical imaging for conformal radiotherapy, J Nucl Med, 41, P273, (2000). 
10.  Scarfone, C., Geng, L., Giorgio, T., Clanton, J., and Hallahan, D.E., Tumor-trageted delivery systems 
guided by radiation, Science (submitted July 2000, under preparation for resubmission). 
11.  Scarfone, C., Jaszczak, R.J., Munley, M.T., Marks, L.B., Gilland, D.R., Greer, K.L., and Coleman, 
R.E., Quantitative pulmonary SPECT for radiotherapy applications, Med Phys, 26, 8, 1579-1587 
(1999). 
12.  Scarfone, C., Geng, L., Holburn, G., Brill, A.B., Dugger, J., Patton, J.A., Sandler, M.P., and Hallahan, 
D.E., Evaluation of radiation guided gene therapy using pinhole imaging and region-of-interest (ROI) 
analysis, Med Phys, 26, 6, 1159 (1999). 
13.  Scarfone, C., Geng, L., Brill, A.B., Holburn, G., Clanton, J.A., Dugger, J., Patton, J.A., Sandler, M.P., 
and Hallahan, D.E., External beam guided drug delivery using radiolabeled microspheres: evaluation 
with nuclear medicine and autoradiography region-of-interest (ROI) techniques, Med Phys, 26, 6, 1160 
(1999). 
14.  Geng, L., Dugger, J., Fleischer, A., Brill, A.B., Donnelly, E., Sandler, M.P., Clanton, J., Holburn, J., 
Scarfone, C., and Hallahan, D.E., Noninvasive imaging of the biodistribution of radiation sensitizing 
gene therapy, Int. J. Radit. Oncol. Biol. Phys., 45, 3, 298 (1999). 
15.  Jaszczak, R.J., Scarfone, C., Marks, L.B., Munley, M.T., Greer, K.L., and Gilland, D.R., Investigation 
of SPECT quantification of lung perfusion imaging: a phantom study, Euro J Nucl Med, 25, 8, pp. 911, 
(1998). 
16.  Scarfone, C., Jaszczak, R.J., Gilland, D.R., Munley, M.T., Marks, L.B., and Coleman, R.E., Bayesian 
SPECT Lung Imaging for Visualization and Quantification of Pulmonary Perfusion, IEEE Trans Nucl 
Sci, 45, 6, 3045-3052 (1998). 
17.  Munley, M.T., Marks, L.B., Scarfone, C., Patz, Ed, Jaszczak, R.J., Sibley, G.S., and Coleman, R.E., 
Multimodality nuclear medicine imaging for 3D lung radiotherapy: challenges and prospects, Lung 
Cancer, 23, 105-114 (1999). 
18.  Marks, L.B., Munley, M.T., Bentel, G.C., Zhou, SM., Hollis, D., Scarfone, C., Sibley, G.S., Kong, 
F.M., Jirtle, R., Jaszczak, R.J., Coleman, R.E., Tapson, V., and Anscher, M., Physical and biological 
predictors of changes in whole lung function following thoracic irradiation, Int. J. Radit. Oncol. Biol. 
Phys., 39, 3, 563-570 (1997). 
19.  Scarfone, C., Jaszczak, R.J., Li, J., Soo, M.S., Smith, M.F., Greer, K.L., and Coleman, R.E., Breast 
tumor imaging using incomplete circular orbit pinhole SPECT: a phantom study, Nuclear Medicine 
Communications, 18, pp. 1077-1086, (1997). 
20.  Wang, H., Scarfone, C., Greer, K.L., Coleman, R.E., and Jaszczak, R.J., Prone breast tumor imaging 
using vertical axis-of-rotation (VAOR) SPECT systems: an initial study, IEEE Trans Nucl Sci, 44, no. 
3, pp. 1271-1276, (1997).  89
21.  Peter, J., Freyer, R., Smith, M.F., Scarfone, C., Coleman, R.E., and Jaszczak, R.J., Nuclear medicine 
image segmentation using a connective network, IEEE Trans Nucl Sci, 44, no. 4, pp. 1583-1590, 
(1997). 
22.  Scarfone, C., Jaszczak, R.J., Gilland, D.R., Munley, M.T., Marks, L.B., and Coleman, R.E., Bayesian 
SPECT Lung Imaging for Visualization and Quantification of Pulmonary Perfusion, 1997 Nuclear 
Science and Medical Imaging Conference, Albuquerque, NM (1997). 
23.  Peter, J., Smith, M.F., Scarfone, C., Coleman, R.E. and Jaszczak, R.J., Synergetically generalized 
expectation maximization algorithm for ECT, 1997 Nuclear Science and Medical Imaging Conference, 
Albuquerque, NM (1997). 
24.  Wang, H., Scarfone, C., Greer, K.L., Coleman, R.E., and Jaszczak, R.J., Breast cancer detection using 
vertical axis-of-rotation (VAOR) SPECT with half-cone beam collimation, Society of Nuclear 
Medicine 44
th Annual Meeting (San Antonio, TX 1997). 
25.  Wang, H., Scarfone, C., Greer, K.L., Coleman, R.E., and Jaszczak, R.J., Prone breast tumor imaging 
using vertical axis-of-rotation (VAOR) SPECT systems: an initial study, Conference Record of the 
1996 Nuclear Science Symposium and Medical Imaging Conference, Anaheim, CA, 3, pp. 1387-1391 , 
(1997). 
26.  Peter, J., Freyer, R., Smith, M.F., Scarfone, C., Coleman, R.E., and Jaszczak, R.J., Nuclear medicine 
image segmentation using a connective network, Conference Record of the 1996 Nuclear Science 
Symposium and Medical Imaging Conference, Anaheim, CA, 3, pp.  1782 - 1786, (1997). 
27.  McCormick, J.W., Jaszczak, R.J., Scarfone, C., and Coleman, R.E., The effect of truncation reduction 
in fan beam transmission for attenuation correction of cardiac SPECT, Conference Record of the 1995 
IEEE Nuclear Science Symposium and Medical Imaging Conference, San Francisco, CA, 1252-1256 
(1996). 
28.  Munley, M.T., Scarfone, C., Marks, L.B., Anscher, M., McAdams, H.P., Patz, E.F., Jaszczak, R.J., 
and Coleman, R.E. Multimodality nuclear medicine imaging in radiation treatment planning for lung 
cancer: challenges and  
prospects, American Society for Therapeutic Radiology and Oncology 38
th Annual Meeting, Anaheim, 
CA (1996). 
29.  Li, J., Jaszczak, R.J., VanMulkan, A, Scarfone, C., Greer, K.L., and Coleman, R.E., Half-cone beam 
collimation for triple-camera SPECT systems. J Nucl Med, 37: pp. 498-502 (1996). 
30.  Jaszczak, R.J., Gilland, D.R., McCormick, J.W., Scarfone, C., and Coleman, R.E., The effect of 
truncation reduction in fan beam transmission for attenuation correction of cardiac SPECT. IEEE 
Trans Nucl Sci, 43, pp. 2255-2262 (1996). 
31.  Marks, L..B., Munley, M.T., Bentel, G., Hollis, D., Zhou, S., Jirtle, R., Kong, F.M., Scarfone, C., 
Antoine, P., Chew, M., Tapson, V., Spencer, D., Sherouse, G., Jaszczak, R.J., Coleman, R.E., and 
Anscher, M., Physical and biological predictors of radiation-induced whole lung injury: early results of 
a prospective study, 1996 American Society for Therapeutic Radiology and Oncology 38
th Annual 
Meeting (Anaheim, CA, 1996). 
32.  Li, J., Scarfone, C., Jaszczak, R.J., Wang, H., and Coleman, R.E. Limited-angular view ML-EM 
pinhole SPECT for breast tumor detection. J Nucl Med 37: 214P (1996). 
33.  Wang, H., Scarfone, C., Jaszczak, R.J., and Coleman, R.E. A new breast tumor imaging approach 
using SPECT systems with non-tiltable cameras: A phantom study. Med Phys 23: pp. 1107 (1996). 
34.  Jang, S.B., Jaszczak, R.J., Gilland, D.R., Hanson, M.W., Scarfone, C., and Coleman, R.E. Effect of 
breast size and shape on defect contrast in myocardial perfusion SPECT imaging. J Nucl Med  37: 
147P (1996). 
35.  Norton, M. G., Scarfone, C., Jian, L., Carter, C.B., and Mayer, J.W., Epitaxy of barium titanate thin-
films grown on MgO by pulsed-laser ablation. J Mater Res, vol. 6,  pp. 2022-2025 (1991). 
36.  Norton, G., Carter, B.C., Scarfone, C, et. al.,  Early stages of growth of barium titanate thin-films 
studied by transmission electron microscopy. Proc XIIth Int Cong for Electron Microscopy 4 (1990). 
37.  Scarfone, C., Norton, M.G., Carter, C.B., Jian, L., and Mayer, J.W., Characterization of BaTiO3 thin-
films deposited by pulsed-laser ablation. Mat Res Soc Symp Proc 201; pp. 183-188 (1990).  90
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Michael G. Stabin 
POSITION TITLE
Assistant Professor 
 
EDUCATION/TRAINING 
INSTITUTION AND LOCATION  DEGREE 
(if applicable) 
YEAR(s) FIELD  OF  STUDY 
University of Florida  B.S.  1981  Environmental Engineering 
University of Florida  M.E.  1983  Environmental Engineering 
University of Tennessee, Knoxville  Ph.D.  1996  Nuclear Engineering 
 
Work Experience: 
2000-Present:      Assistant Professor, Vanderbilt University 
Duties include giving classes at the graduate level in radiological protection; performing 
support duties for the Vanderbilt Hospital and the Department of Radiology, including 
radiation dose calculations for patients; orienting students in their graduate work; and 
performing research.  Research results are routinely presented at national and 
international conferences.   
 
1998-2000:         Visiting Professor, Universidade Federal de Pernambuco 
Duties include giving classes at the graduate level in radiological protection, orienting      
students in their graduate work, and performing research.  Research results are routinely 
presented at national and international conferences.  Some outside teaching duties were 
performed as well, in short courses, seminars, etc. 
 
1983-1998:         Scientist, Radiation Internal Dose Information Center, Oak Ridge Associated Universities,  
                Oak Ridge, Tennessee 
Duties include responding to requests for information about problems in internal 
dosimetry, performing research in internal dosimetry, presenting results of research at 
scientific meetings and in the open literature, lecturing in training courses in internal 
dosimetry and radiation safety, and assisting graduate students in their research and in 
developing and defending their theses/projects. Training course experience has included 
lecturing in one week courses in Occupational Internal Dosimetry and 
Radiopharmaceutical Internal Dosimetry, coordinating both courses, giving lectures in 
one week courses on uses of radionuclides in medicine and in several courses for the 
Radiation Emergency Assistance Center and Training Site (REAC/TS) in health physics 
in radiation accidents, health physics for medical personnel and others, mainly on the 
topic of internal dosimetry. In addition, many lectures have been given, mostly on an 
invited basis, at short courses at technical meetings including the Health Physics Society 
(Professional Enrichment Program), the Society of Nuclear Medicine, the American 
Association of Physicists in Medicine, the Campus Radiation Safety Officers' Meeting, 
the Drug Information Association, the American Pharmaceutical Association, and the 
World Congress on Medical Physics and Biomedical Engineering. 
 
1980-1983:          Department of Environmental Engineering; Student assistant and graduate assistant  
Assisted Dr. Charles Roessler in several projects at the University of Florida involving 
the radiological impacts of phosphate mining on the environment in Florida. Also 
assisted Dr. Roessler on several projects for private firms in Florida, also studying 
environmental impacts of naturally-occurring radionuclides in phosphate and phosphate 
by-products. 
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Honors: 
  1996 Elda E. Anderson Award Recipient, Health Physics Society 
 
 
Certification: 
  Certified Health Physicist – 1988, Recertified – 1992, 1996, 2000 
 
Professional Societies: 
  Health Physics Society - 
             President, Medical Section, 1993-present (first section president) 
              Associate Editor, Health Physics Journal, 1992-present 
            Secretary (1989-1990), Council Member (1986), chair of Public Education Committee                                            
              (1983-1985),  
         President-Elect (1998), East Tennessee Chapter of the Health Physics Society. 
 Sigma  Xi 
 Tau  Beta  Pi 
  Society of Nuclear Medicine, Associate Editor, Journal of Nuclear Medicine 
  Editorial Board, Cancer Biotherapy & Radiopharmaceuticals, 1998- pres. 
 
Committee Activities: 
  Human Subjects Radiation Committee, Vanderbilt University, 2001 - pres. 
  Health Physics Society Electronic Media Committee, 2001 – pres. 
Special Task Group of the American Association of Physicists in Medicine on dosimetry for 
monoclonal antibodies - 1988 - present 
  Special Task Group of the Society of Nuclear Medicine's Medical Internal Radiation Dose (
  MIRD) committee to develop a new model for the urinary bladder - 1985 - 1992  
Special Task Group of the Society of Nuclear Medicine's Medical Internal Radiation Dose 
(MIRD) committee to develop a radiation dosimetry model for adults and children for Tc-99m 
MAG3 - 1991 - present 
Special Task Group of the International Commission on Radiological Protection on Dose to 
Patients from Radiopharmaceuticals - 1991 - present 
 
Publications: 
Author or Co-author on 118 full articles or book chapters and 62 abstracts. 
Most Recent: 
1.  Stabin, M. and Zaidi, H. (2002) Monte Carlo codes for use in therapeutic nuclear medicine.  
In Therapeutic applications of Monte Carlo calculations in nuclear medicine.  (Eds, Zaide, H. 
and Sgouros, G.)  Institure of Physics Publishing, London, PP. 286-309. 
2.  Bouchet, L., Bolch, W., Stabin, M., Eckerman, K., Poston, J.W. and Brill, A.B. (2002) Monte 
Carlo methods and mathematical models for the dosimetry of skeleton and bone marrow.  In 
Therapeutic applications of Monte Carlo calculations in nuclear medicine.  (Eds, Zaidi, H. 
and Sgouros, G.)  Institute of Physics Publishing, London, pp. 310-323. 
3.  Stabin, M. and Duggan, F. (2002) Monte Carlo modeling of dose distributions in 
intravascular radiation therapy.  In Therapeutic applications of Monte Carlo Calculations in 
nuclear medicine.  (Eds, Zaidi, H. and Sgouros, G.)  Institute of Physics Publishing, London, 
pp. 310-323. 
4.  Stabin, MG, da Luz CQPL.  New Decay Data For Internal and External Dose Assessment, 
Health Phys.  83 (4) :471-475, 2002. 
5.  M.G. Stabin, K.F. Eckerman, W.E. Bolch, L.G. Bouchet, and P.W. Patton.  Evolution and 
Status of bone and Marrow Dose Models Cancer Biotherapy and Radiophermaceuticals, 17 
(4) :427-434, 2002. 
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MIRDOSE Software: 
I developed and wrote this software package, which has been distributed to over 1200 
sites worldwide.  It automates the calculation of internal dose estimates, primarily in 
nuclear medicine. 
 
Radsafe Professional Mailing List: 
When the Radsafe mailing list, which has about 2000 members worldwide and post 10-50 
e-mail messages per day on the topic of radiation protection, was moved from the 
University of Illinois at Urbana-Champaign campus, I had it moved to the Vanderbilt 
campus and took over as list owner/manager. 
 
Students Supervised: 
1.  David Marshall, Master’s student, University of Texas, 1993.  Subject - development of phantom 
representing woman at 6 months’ pregnancy.  Result - received Master’s degree, completed thesis, 
thesis became part of publication of ORNL report on 4 phantoms representing the adult female at 
different stages of pregnancy. 
 
2.  Julie Behm, Master’s student, University of Florida, 1994.  Supervised on several projects involving 
new models for internal dosimetry.  Also served on advisory committee for Master’s degree.  Result - 
received Master’s degree, completed thesis. 
 
3.  Joy Russell, University of Tennessee, 1995.  Subject - use newly developed pregnant female phantoms 
to calculate radiation dose estimates at all stages of pregnancy for many radiopharmaceuticals.  Result 
- received Master’s degree, completed thesis, received student award from Health Physics Society, two 
full articles published in Health Physics Journal, 1997. 
 
4.  Michalene Rodriguez, Colorado State University, 1996.  Subject - develop kinetic model for kinetics 
of iodine in subjects whose thyroids have been removed surgically or with radioiodine.  Result - 
received Master’s degree, completed project report.  Publication of work pending, awaiting 
collaboration with CNEN-IRD, Rio de Janeiro. 
 
5.  Helio Yoriyaz, CNEN-IPEN, Sao Paulo, Brazil, 1996-1997.  Subject - investigate ability of radiation 
transport software to perform patient-specific dosimetry.  Result - project has good progress, will be 
used for PhD dissertation, work ongoing. 
 
6.  Gina Cotlet, Ohio State University, 1997.  Subject - develop model for bone marrow response in 
radioimmunotherapy.  Result - student is using results of Master’s thesis (kinetic model for cell 
division) with data on marrow response to radiation from radioimmunotherapy applications, work 
ongoing. 
 
7.  Lydia Luz, Departamento de Energia Nuclear, 1998- pres. Subject – evaluate existing bone marrow 
dose models and investigate how to adapt them to individual patients in nuclear medicine therapy. 
 
8.  Fabiana Farias da Lima, Departamento de Energia Nuclear, 1998- 2002. Subject – evaluate methods 
for patient-specific imaging and treatment planning for thyroid cancer patient treatment. 
 
9.  Eduardo Loureiro, Departamento de Energia Nuclear, 1998- 2002. Subject – adapt voxel-based images 
to the calculation of radiation doses from diagnostic radiology in dentistry. 
 
10.  Laelia P. Campos, Departamento de Energia Nuclear, 1998- 2000. Subject – calculation of radiation 
dose distributions in intravascular brachytherapy. 
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NAME 
 
Teng, Ming 
POSITION TITLE 
 
Assistant Professor    
EDUCATION/TRAINING 
INSTITUTION AND LOCATION 
DEGREE 
(if applicable)  YEAR(s) FIELD  OF  STUDY 
Shanghai Medical University 
Medical College of Wisconsin 
MD 
PhD 
1987 
1993 
Medicine 
Molecular Immunology 
Employment and Experience 
1987-88  Fellow, Shanghai Medical University, Shanghai, P.R. China 
1993-94  Resident, Internal Medicine, University Hospital of Columbia University, New 
York, New York 
1994-97  Residence, Radiation Oncology, New York Medical College, Valhalla, New 
York 
1997-98  Instructor, Radiation Oncology, Vanderbilt University, Nashville, Tennessee 
1998-Present  Assistant Professor, Radiation Oncology, Vanderbilt University, Nashville, 
Tennessee 
 
Professional Societies:  
American College of Radiology 
American College of Radiation Oncology 
American Society for Therapeutic Radiology and Oncology  
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